Introduction {#s1}
============

Many cellular processes, such as cell morphogenesis, migration, and asymmetric cell division, require eukaryotic cells to alter polarity and growth patterns ([@bib53]; [@bib92]; [@bib109] [@bib46]). Understanding the conserved mechanisms by which cells tune polarized cell growth has implications for studies of neuronal cell morphogenesis, neurodegenerative diseases, stem cell differentiation, and cancer ([@bib116]; [@bib92]; [@bib112]; [@bib93]). The fission yeast *Schizosaccharomyces pombe* is an excellent model system to study cell morphogenesis and growth because cells have a defined cylindrical shape that enables straightforward evaluation of changes in growth and polarity. Under exponential growth conditions, fission yeast cells display a paradigmatic pattern of cell growth, growing in a monopolar fashion during early interphase and activating bipolar growth at the new cell tip once a minimal cell length has been achieved ([@bib71]). Further, *S. pombe* displays a distinct morphological response to nutrient deprivation, which causes cells to divide at a shorter cell length and grow in a monopolar fashion ([@bib90]; [@bib114]; [@bib113]).

The NDR (Nuclear Dbf2-Related) kinase family with roles in cell morphogenesis, cell growth and proliferation, mitosis, and development, is highly conserved in cells ranging from yeast to mammalian neurons ([@bib100]; [@bib101]; [@bib119]; [@bib35]). In humans, this subset of the AGC kinase group comprises NDR1 and NDR2 and the closely related kinases LATS1 (large tumor suppressor 1) and LATS2 ([@bib35]), which function downstream of the MST/Hippo kinases ([@bib69]). While LATS1 and LATS2 kinases are central to the Hippo pathway that plays a role in organ size and tumor suppression, dysregulation of NDR kinases has been implicated in cancers such as progressive ductal cell carcinoma, melanoma, non--small-cell lung cancer, and T-cell lymphoma ([@bib1]; [@bib70]; [@bib33]; [@bib83]; [@bib14]). In addition to their link to cancer, NDR kinases function also in neuronal growth and differentiation, dendritic branching, and dendritic tiling, and have been implicated in memory and fear conditioning ([@bib22]; [@bib117]; [@bib48]; [@bib89]). Recent work has shown that mammalian NDR1 and NDR2 promote polarity in neurons upstream of the polarity protein Par3 ([@bib115]). However, the mechanisms by which NDR kinases control cell growth and polarity are not fully understood. The fission yeast NDR kinase Orb6 is a central component of the conserved morphogenesis (MOR) regulatory network ([@bib35]). We previously showed that NDR kinase Orb6 has a role in the establishment of cell polarity and the control of polarized cell growth ([@bib100]; [@bib101]). Orb6 kinase regulates cell polarity, in part, by spatially controlling conserved GTPase Cdc42 ([@bib18]), via inhibitory phosphorylation of Cdc42 guanine exchange factor (GEF) Gef1 ([@bib17]).

Here, we describe a novel role for Orb6 kinase, genetically separable from its control of the Cdc42 pathway, in promoting polarized cell growth by inhibiting translational repression. Translational repression, carried out in part by the assembly of cytoplasmic granules of ribonucleoprotein particles (RNPs), is a quick and reversible cellular strategy for inhibiting cell growth in response to stress, such as nutritional deprivation, oxidative stress, or osmotic stress ([@bib13]; [@bib19]; [@bib44]; [@bib41]). P-bodies, stress granules, and other RNPs such as neuronal transport granules and germ granules play important roles in mRNA regulation with implications for human diseases such as ALS, frontotemporal lobar degeneration, and viral infection ([@bib80]; [@bib11]). P-bodies in particular contain mRNA decay machinery and serve as sites of storage or degradation for mRNAs during times of cellular stress ([@bib19]). In this work, we describe a novel mechanism whereby NDR kinase Orb6 negatively regulates the recruitment of mRNA-binding protein Sts5 into RNP particles and Sts5 localization to P-bodies at least in part by promoting Sts5 interaction with 14-3-3 protein Rad24. This mechanism of control prevents the degradation of mRNAs encoding proteins important for polarized cell growth and cell morphogenesis during exponential cell growth, and promotes morphological adaptation during nutritional stress.

Results {#s2}
=======

Loss of RNA-binding protein Sts5 suppresses the cell viability defects of *orb6* mutants {#s2-1}
----------------------------------------------------------------------------------------

We observed that loss of Orb6 kinase activity by chemical inhibition of analog-sensitive Orb6-as2 kinase by the ATP analogue 1-NA-PP1 leads to cell separation defects ([Figure 1A,c; B](#fig1){ref-type="fig"}) and slow growth, in addition to polarity defects ([@bib18]; [@bib17]). By complementation screening of the *orb6-as2* allele with mutants of other *orb* genes ([@bib88]; [@bib100]), we found that *sts5* mutants (allelic to *orb4*; see [Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}) suppress the cell-separation defect associated with chemical inhibition of Orb6-as2 kinase ([Figure 1A,d](#fig1){ref-type="fig"}; [Figure 1B](#fig1){ref-type="fig"}; [@bib100]) as compared to control cells ([Figure 1A,c](#fig1){ref-type="fig"}; [Figure 1B](#fig1){ref-type="fig"}). *sts5* encodes an mRNA-binding protein with significant sequence homology to Ribonuclease II (RNB)--domain and Ribonuclease R--domain proteins ([@bib96]; [@bib40]). Closest homologues of Sts5 include *S. cerevisiae* Ssd1 ([@bib40]), *S. pombe* Dis3L2, and the human exonuclease Dis3L2, which has been associated with diseases such as Perlman syndrome and Wilm's tumor, as well as Rrp44/Dis3 ([Figure 1C](#fig1){ref-type="fig"}) ([@bib61]; [@bib82]; [@bib59]; [@bib3]). Sts5 and Dis3L2 contain conserved domains (cold shock domains CSD1 and CSD2 and the S1 domain) that mediate interaction with the single-stranded RNA substrate ([@bib24]). However, both Sts5 and Dis3L2 lack the PIN domain and CR3 signature amino acids that are implicated in the association of Rrp44/Dis3 to the exosome (Indicated by • in [Figure 1C](#fig1){ref-type="fig"}) ([@bib61]; [@bib86]; [@bib60]; [@bib82]). Furthermore, Sts5 lacks conserved amino acids involved in RNA hydrolysis (marked by **▲** in [Figure 1C](#fig1){ref-type="fig"}), indicating that it is unlikely to have exonuclease activity ([@bib98]; [@bib40]).10.7554/eLife.14216.003Figure 1.Loss of RNA-binding protein Sts5 suppresses the cell viability defects of *orb6* mutants.(**A**) Deletion of *sts5* suppresses the cell separation phenotype of analog-sensitive *orb6-as2* mutants. (**a**) wild-type, (**b**) *sts5∆*, (**c**) *orb6-as2* and (**d**) *orb6-as2 sts5∆* mutants treated with 50 μM 1-NA-PP1 inhibitor for 2 hr at 32°C. Bar = 5 μm. (**B**) Septation index quantification of cells in experiment shown in **A** based on 3 independent experiments (N\>295 per strain). Orb6-as2 cells exhibit a significantly higher septation index as compared to control cells (*P *= 0.0004) and as compared to *orb6-as2 sts5∆* double mutants (*P *= 0.0011). P values were determined using analysis of variance (ANOVA) with SPSS statistics package 22.0, followed by Tukey's HSD test. Error bars indicate SD. (**C**) Sts5 protein sequence includes the RNB domain (a.a. 531--975), with homology to the catalytic domain of *E. coli* ribonuclease II, three conserved OB-fold domains that promote interaction with RNA, the CSD1 (a.a. 293--353), CSD2 (a.a. 430--524), and S1 (a.a. 981--1031) domains. Sts5 is related to the exoribonuclease Dis3L2 that is conserved from *S. pombe* to humans. ▲ indicates 3 catalytic residues in RNB domain. • indicates CR3 motif residues for exosome targeting. (**D**) Interactions between MOR network proteins. Mor2 serves as a scaffold that enables activation of Mob2-bound Orb6 by the Nak1-Pmo25 complex (**o** indicates 2-hybrid interaction; • indicates IP interaction). (**E**) *sts5-276* mutation suppresses the temperature-sensitive growth of MOR mutants. The indicated cells were spotted on YPD solid medium (approximately 5 × 10^4^ cells in the left spots for each plate and then diluted 4-fold in each subsequent spot) and incubated at 25°C, 34°C, and 36°C for 3 days.**DOI:** [http://dx.doi.org/10.7554/eLife.14216.003](10.7554/eLife.14216.003)10.7554/eLife.14216.004Figure 1---figure supplement 1.Loss of RNA-binding protein Sts5 does not suppresses the polarity defects observed upon Orb6-as2 kinase inhibition.(**A**) Description of *orb4-A9* and *sts5-276* early stop codon mutations in the *sts5* gene. No significant differences were observed in the phenotype of these mutations as compared to the *sts5∆* deletion. (**B**) Loss of *sts5 (sts5∆*) does not suppress the cell polarity phenotype of *orb6-as2* cells following Orb6 kinase inhibition for 5 hr. Bar = 5 μm. (**C**) Loss of *sts5 (orb4-A9* allele) does not suppress CRIB-GFP mislocalization in *orb6-as2* mutants. Cells were grown at 32°C and treated with 1-NA-PP1 inhibitor for 30 mins. Bar = 10 μm. Note that only the subset of cells that do not contain a septum (non-septating cells) were analyzed. (**D**) Quantification of CRIB-3xGFP localization as shown in (**C**) (N≥70 cells per condition).**DOI:** [http://dx.doi.org/10.7554/eLife.14216.004](10.7554/eLife.14216.004)10.7554/eLife.14216.005Figure 1---figure supplement 2.Deletion of *gef1* or *dis3L2 *does not suppress the growth defect observed upon Orb6-as2 kinase inhibition.(**A**) *gef1Δ* cells do not suppress the growth defect observed upon Orb6-as2 kinase inhibition. Growth properties of the *gef1Δ orb6-as2* double mutant compared with wild-type, *orb6-as2*, and *gef1Δ* cells were assayed by spotting the indicated cells on minimal solid medium in the presence of DMSO or 10 μM 1-NA-PP1 inhibitor and incubated the plates at 32°C for 3 days (approximately 5 × 10^5^ cells in the left spots for each plate and then diluted 10-fold in each subsequent spot). (**B**) Loss of the sts5 homologue *dis3L2* does not suppress the growth defect observed upon Orb6-as2 kinase inhibition. Growth properties of the *dis3L2Δ orb6-as2* double mutant compared with wild-type, *orb6-as2*, and *dis3L2Δ* cells were assayed by spotting the indicated cells on minimal solid agar as described in **A**.**DOI:** [http://dx.doi.org/10.7554/eLife.14216.005](10.7554/eLife.14216.005)

Next, we investigated whether *sts5Δ* suppresses the loss of viability observed with temperature-sensitive *orb6* mutants and mutants of other components of the Orb6 pathway ([@bib100]; [@bib101]). Orb6 kinase belongs to the morphogenesis (MOR) network, which includes Nak1 kinase and its binding partner Pmo25, the scaffolding protein Mor2, and the Orb6 binding partner Mob2 ([Figure 1D](#fig1){ref-type="fig"}) ([@bib42]; [@bib38]). As with *orb6* mutants, temperature-sensitive MOR mutants exhibit a loss of viability at the restrictive temperature. In a spot growth assay, we found that the *sts5-276* mutation (which truncates the *sts5* gene to a short 53-bp fragment; see [Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}) suppresses the temperature-sensitive growth defect associated with *orb6* mutation, as well as the growth defects of other MOR network mutants ([Figure 1E](#fig1){ref-type="fig"}).

Finally, we tested the idea that the function of *sts5* deletion in suppressing the loss of viability of *orb6* mutant cells is independent of Cdc42 GTPase. We found that *sts5* deletion does not suppress the cell rounding induced by prolonged Orb6 kinase inhibition ([Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}). Further, mislocalization of the Cdc42 reporter CRIB-GFP in *orb6* mutants ([@bib94]; [@bib36]), a hallmark of Orb6 kinase inhibition ([@bib18]), is not suppressed by loss of *sts5* ([Figure 1---figure supplement 1C and 1D](#fig1s1){ref-type="fig"}). Conversely, deletion of the Cdc42 GEF *gef1* does not suppress the loss of viability of *orb6* mutants ([Figure 1---figure supplement 2A](#fig1s2){ref-type="fig"}), while it suppresses the polarity defect associated with Orb6 kinase inhibition ([@bib18]).

Together, these results suggest that Sts5 mediates the cell separation defects and loss of viability observed in *orb6* mutants. Further, this novel role of Orb6 kinase in growth control is genetically separable from its previously established function in the spatial control of Cdc42 GTPase.

Sts5 proteins are recruited into cytoplasmic puncta during mitosis and during nutritional starvation {#s2-2}
----------------------------------------------------------------------------------------------------

We used fluorescence microscopy to study the localization of Sts5-3xGFP. We found that during exponential growth Sts5-3xGFP localization is mostly diffuse in the cytoplasm during interphase (I) ([Figure 2A](#fig2){ref-type="fig"}). Sts5 coalesces into cytoplasmic puncta during mitosis as previously reported ([@bib99]).10.7554/eLife.14216.006Figure 2.Sts5 proteins assemble into puncta during mitosis and during nutritional starvation.(**A**) Sts5-3xGFP proteins coalesce into cytoplasmic particles in cells undergoing mitosis (M) but appear mostly diffuse in the cytoplasm of growing interphase (I) cells (**a, c**). (**b**) P-body formation, as visualized by P-body marker Dcp1-mCherry is not induced in mitotic cells. Bar = 5 μm. (**B**) Sts5-3xGFP proteins are recruited and colocalize with the P-body marker Dcp1-mCherry upon growth for 1 hr in minimal medium minus glucose (**b, e, h**). Sts5-3xGFP recruitment and colocalization with Dcp1-mCherry in P-bodies also occurs upon 1 hr of growth in minimal medium minus nitrogen (**c, f, i**). Sts5-3xGFP recruitment was observed as early as 15 min after transfer to glucose- or nitrogen-depleted medium. Images are deconvolved projections from 12 Z-stacks separated by a step size of 0.3 μm. Experiment was performed using prototrophic strain FV2267. Bar = 5 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.14216.006](10.7554/eLife.14216.006)10.7554/eLife.14216.007Figure 2---figure supplement 1.Sts5 protein contains an intrinsically disordered domain.Sts5 protein contains an intrinsically disordered domain as predicted by DisProt software (using VL3, VSL2B, and VLXT algorithms) (DisProt - Database of Protein Disorder, RRID:[SCR_007097](https://scicrunch.org/resolver/SCR_007097)).**DOI:** [http://dx.doi.org/10.7554/eLife.14216.007](10.7554/eLife.14216.007)

We found that upon nutrient starvation Sts5-3xGFP proteins rapidly coalesce into distinct, larger cytoplasmic puncta. Many of these puncta colocalize with P-body (Processing body) marker Dcp1-mCherry, a component of the mRNA decapping complex ([@bib103]). Sts5 localization to the P-bodies is particularly strong during glucose deprivation ([Figure 2B,b,h](#fig2){ref-type="fig"}) and occurs also during nitrogen starvation, although puncta appear smaller and co-localization of Sts5 with Dcp1 is partial ([Figure 2B,c,i](#fig2){ref-type="fig"}). Conversely, Sts5 recruitment into puncta during mitosis occurs in the absence of substantial P-body formation, as visualized with P-body marker Dcp1-mCherry ([Figure 2A](#fig2){ref-type="fig"}). Consistent with these findings, Sts5 contains a region predicted to be intrinsically disordered in the first 301 amino acids of the Sts5 protein, a feature shared by many proteins that undergo assembly into RNP particles ([@bib58]; [@bib77]; [@bib21]; [@bib104]; [@bib43]; [@bib31]) ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). These results indicate that Sts5 proteins can organize in cytoplasmic puncta during mitosis and in response to nutritional stress. Furthermore, these puncta co-localize with P-bodies following glucose or nitrogen starvation.

Loss of Sts5 leads to increased levels of mRNAs involved in growth control and bipolar growth activation {#s2-3}
--------------------------------------------------------------------------------------------------------

It is possible that Sts5 modulates cell growth by controlling the levels of the mRNAs it binds. To investigate the functions of Sts5-regulated transcripts, we first used microarray analysis to identify mRNAs that are elevated (at least 1.9-fold) in *sts5Δ* mutants as compared to wild-type cells, under exponential growth conditions (See [Figure 3---source data 1](#SD1-data){ref-type="supplementary-material"}). This analysis identified 140 mRNAs, and showed significant overrepresentation of genes with roles in polarized cell growth, adhesion and cell wall biogenesis by gene ontology enrichment analysis ([Figure 3](#fig3){ref-type="fig"}, \*) (See [Figure 3---source data 1](#SD1-data){ref-type="supplementary-material"}). Remarkably, we identified *ssp1, cmk2, tea5/ppk2, ksg1* and *lkh1*, which encode protein kinases with a role in the activation of bipolar cell growth ([Figure 3](#fig3){ref-type="fig"}; [Figure 3---source data 1](#SD1-data){ref-type="supplementary-material"}) ([@bib50]). Intriguingly, these mRNAs encoding polarity regulators all contain a consensus sequence in their 5'UTR which functions as a potential recognition sequence for targets of the *S. cerevisiae* homolog of Sts5, Ssd1 ([Figure 3](#fig3){ref-type="fig"}, †) ([@bib37]) ([@bib105]). The fully categorized list of mRNAs identified in the microarray analysis includes mRNAs involved in cell wall biogenesis and secretion, cytoskeletal organization, nutrient transport, and meiosis (See [Figure 3---source data 1](#SD1-data){ref-type="supplementary-material"}).10.7554/eLife.14216.008Figure 3.mRNAs detected at higher levels in sts5∆ cells by microarray analysis.Total mRNA was extracted from *sts5∆* and control cells for microarray analysis. A complete list of mRNAs increased in *sts5∆* cells (≥1.9 fold) is shown in [Figure 3---source data 1](#SD1-data){ref-type="supplementary-material"}. Several of these mRNAs have established functions in bipolar growth activation and contain putative Sts5-binding sites in their 5' UTRs ([@bib37]; [@bib105]). \*Gene ontology enrichment analysis of terms that are significantly enriched among the set of mRNAs with *sts5Δ*/WT ratio ≥1.90 in the microarray results. Fold enrichment plotted per gene ontology category among all significant terms (*P*\<0.05, modified Fisher Exact P-value with the Benjamini P-value correction) for Cellular Compartment (CC), Biological Process (BP) and Molecular Function (MF) Gene Ontology terms. ^†^Sts5 binding site: HNNYAHTCHWW (where H = A,T,C / N = A,T,C,G / Y = C,U / W = T,A).**DOI:** [http://dx.doi.org/10.7554/eLife.14216.008](10.7554/eLife.14216.008)10.7554/eLife.14216.009Figure 3---source data 1.Microarray analysis results.A complete list of mRNAs detected at higher levels (≥1.9 fold) in* sts5∆* cells by microarray analysis.**DOI:** [http://dx.doi.org/10.7554/eLife.14216.009](10.7554/eLife.14216.009)

The mRNAs encoding proteins with known roles in polarized cell growth were selected for further analysis by qPCR, which confirmed that *sts5Δ* cells exhibit increased levels of *ssp1, cmk2, tea5/ppk2, lkh1, efc25*, and *psu1* mRNA, genes with diverse functions in cell morphogenesis ([Figure 4A](#fig4){ref-type="fig"}) ([Figure 3;](#fig3){ref-type="fig"} [Figure 3---source data 1](#SD1-data){ref-type="supplementary-material"}). Further, we determined that Sts5-3xGFP protein co-purifies with *efc25, ssp1*, and *psu1* mRNAs ([Figure 4B](#fig4){ref-type="fig"}). Consistent with a functional interaction with *sts5* and *orb6, ssp1* was previously identified as an extragenic suppressor of *sts5* mutants ([@bib67]), while *psu1* functions as a multicopy suppressor of *orb6* mutants ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}).10.7554/eLife.14216.010Figure 4.Loss of Sts5 leads to increased levels of mRNAs involved in growth control and bipolar growth activation.(**A**) qPCR analysis confirmation that several of these transcripts are more abundant in the *sts5∆* strain as compared to control cells based on 3 independent experiments. Tea4 is shown as an example of a transcript that is not altered. Housekeeping genes were *nda3*, *act1*, *cdc2*, and *cdc22*. Error bars indicate SD. (**B**) Interaction of *ssp1, efc25,* and *psu1* mRNAs with Sts5-3xGFP as established by co-immunoprecipitation with Sts5-3xGFP followed by qPCR as described in the Materials and Methods. c*dc2* is shown as an example of a transcript that does not interact with Sts5-3xGFP. Error bars indicate SD. Three independent experiments were performed. (**C**) Western blotting against Ssp1-HA performed as described in Materials and Methods in WT and *sts5Δ* cells cultured in YE medium at 25°C and 36°C. Tubulin levels were determined as a loading control. (**D**) Quantification of Ssp1-HA/Tubulin ratio normalized to WT levels was based on 3 independent experiments. Change in Ssp1-HA level is significantly greater in *sts5∆* cells as compared to controls at 36°C (*P *= 0.034, Student's t-test). Error bar=SD. (**E**) Western blotting against Ssp1-HA performed as described in Materials and Methods in WT and *edc3Δ* and *pdc1Δ* cells cultured in supplemented minimal medium at 30°C. Tubulin levels were determined as a loading control. (**F**) Quantification of Ssp1-HA/Tubulin ratio normalized to WT levels at 25°C based on 3 independent experiments. Change in Ssp1-HA level is significantly greater in *edc3Δ (P *= 0.018, Student's t-test) and *pdc1Δ (P *= 0.0154, Student's t-test) cells as compared to controls. Error bar = SD. (**G**) RNA FISH visualization of *ssp1* mRNA in fixed cells cultured for 20 min in supplemented minimal medium containing 0% glucose. Hybridization used 20-mer DNA oligos (Stellaris) labeled with Quasar 705 fluorochromes. Bar = 5 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.14216.010](10.7554/eLife.14216.010)10.7554/eLife.14216.011Figure 4---figure supplement 1.Overexpression of Psu1 suppresses the temperature-sensitive growth defect of *orb6-25* mutant cells.Psu1 was expressed in *orb6-25* and control cells from the pRep3X plasmid under the control of the *nmt1* promoter, at restrictive temperature (36°C), in the presence (**a**) or absence (**b**) of Thiamine.**DOI:** [http://dx.doi.org/10.7554/eLife.14216.011](10.7554/eLife.14216.011)10.7554/eLife.14216.012Figure 4---figure supplement 2.Deletion of s*ts5 *alters cell shape and Myc-Efc25 protein levels.(**A**) Calcofluor staining of WT (a and c) and *sts5∆* (b and d) cultured in YE medium at 25°C and 36°C. Bar = 5 μm. (**B**) Western blotting against Myc-Efc25 performed as described in Materials and Methods in WT and *sts5Δ* cells cultured in minimal medium at 25°C. Tubulin levels were determined as a loading control. (**C**) Quantification of Myc-Efc25/Tubulin ratio normalized to WT levels at 25°C based on 3 independent experiments. Change in Myc-Efc25 level is significantly greater in *sts5Δ* cells as compared to controls (*P *= 0.0087, Student's t-test).**DOI:** [http://dx.doi.org/10.7554/eLife.14216.012](10.7554/eLife.14216.012)10.7554/eLife.14216.013Figure 4---figure supplement 3.Extent of colocalization between *ssp1* mRNA, Sts5-3xGFP, and Dcp1-mCherry in fixed cells cultured in the presence and absence of glucose.(**A**) RNA FISH visualization of *ssp1* mRNA in fixed cells cultured for 20 min in supplemented minimal medium containing 2% glucose or 0% glucose. Hybridization used 20-mer DNA oligos (Stellaris) labeled with Quasar 705 fluorochromes. Bar = 5 μm. (**B**) Object-based quantification of the proportion of *ssp1* puncta contained within Sts5-3xGFP or Dcp1-mCherry puncta in the presence and absence of glucose. For *ssp1* dots contained within Sts5 granules in 0% glucose vs 2% glucose, *P *= 0.0293 (Student's t-test). For *ssp1* dots contained within Dcp1 granules in 0% glucose vs 2% glucose, *P *= 0.0011 (Student's t-test). Object-based quantification based on the distance between centers of mass performed using ImageJ plugin JACoP ([@bib5]). Error bars denote SD among the means of 3 independent experiments (N≥25 cells). For details, see Materials and methods. (**C**) Object-based quantification of the proportion of Sts5-3xGFP or Dcp1-mCherry puncta containing *ssp1* puncta in the presence and absence of glucose. For Sts5 granules containing *ssp1* dots in 0% glucose vs 2% glucose, *P *= 0.0042 (Student's t-test). For Dcp1 granules containing *ssp1* dots in 0% glucose vs 2% glucose, *P *= 0.0053 (Student's t-test). Object-based quantification based on the distance between centers of mass performed using ImageJ plugin JACoP ([@bib5]). Error bars denote SD among the means of 3 independent experiments (N≥25 cells). For details, see Materials and Methods.**DOI:** [http://dx.doi.org/10.7554/eLife.14216.013](10.7554/eLife.14216.013)

We chose to measure protein levels of HA-tagged Ssp1 and Myc-tagged Efc25 to gauge how Sts5 regulation of *ssp1* and *efc25* mRNAs affected the levels of Ssp1 and Efc25 proteins. We determined that Ssp1 protein levels significantly increase in *sts5∆* mutants, as compared to controls, when cells are exposed to higher temperatures (36°C; [Figure 4C,D](#fig4){ref-type="fig"}). Interestingly, *sts5∆* cells display a temperature-sensitive morphological phenotype, growing over a wider area of the cell surface and developing a rounded cell shape at 36°C ([Figure 4---figure supplement 2A,d](#fig4s2){ref-type="fig"}). Consistent with increased Ssp1 protein levels playing a role in promoting abnormal morphogenesis, the aberrant morphological phenotype of sts5 mutants is partially suppressed by loss of *ssp1* ([@bib67]; [@bib96]). In addition, we determined that loss of *sts5* leads also to increased levels of Myc-Efc25 proteins as compared to the control *sts5+* cells ([Figure 4---figure supplement 2B,C](#fig4s2){ref-type="fig"}). Taken together, these findings indicate a role for Sts5 in regulating the cellular abundance of specific mRNAs, affecting cell morphology in particular during cell stress.

Next, we tested if loss of P-body components affects the protein levels of Ssp1. We assayed the levels of Ssp1 protein in *pdc1∆* and *edc3∆* mutant cells. Both Pdc1 and Edc3 are P-body components and bind to the mRNA decapping complex catalytic subunit Dcp2 ([@bib25]; [@bib103]). *pdc1* encodes an mRNA decapping scaffolding protein and *pdc1∆* mutants display reduced levels of P bodies and reduced mRNA decapping ([@bib103]). *edc3* encodes an enhancer of mRNA decapping and *edc3∆* mutants display decreased decapping of nuclear-transcribed mRNA ([@bib25]; [@bib103]). We found that levels of Ssp1 protein are increased, as compared to tubulin control, in both the *pdc1∆* and *edc3∆* mutant backgrounds ([Figure 4E,F](#fig4){ref-type="fig"}). This effect is seen even in the absence of starvation, during exponential cell growth, consistent with the idea that P-body components modulate mRNA abundance even in the absence of large P-body formation ([@bib20]; [@bib23]).

Finally, we tested if *ssp1* mRNA localizes to the P-bodies during glucose starvation, using RNA FISH methodology. We found that *ssp1* mRNA readily co-localizes to Sts5- and Dcp1-containing granules in cells re-diluted in minimal medium (EMM) lacking glucose for 20 min ([Figure 4G](#fig4){ref-type="fig"}; [Figure 4---figure supplement 3A--C](#fig4s3){ref-type="fig"}). Conversely, no co-localization was observed in control cells re-diluted in growth medium containing 2% glucose ([Figure 4---figure supplement 3A-C](#fig4s3){ref-type="fig"}). Our data reveal a role for Sts5 and P-body components in regulating the levels of *ssp1* mRNA and Ssp1 protein.

Orb6 kinase activity inhibits Sts5 recruitment and localization to P-bodies {#s2-4}
---------------------------------------------------------------------------

To test the role of Orb6 kinase in the control of Sts5, we used the analog-sensitive *orb6-as2* mutant to determine whether loss of Orb6 kinase function alters the localization of Sts5. In *orb6-as2* cells treated with the 1-NA-PP1 inhibitor, Sts5-3xGFP rapidly coalesces into cytoplasmic puncta that colocalize with the P-body marker Dcp1-mCherry ([Figure 5A, d, h, and l](#fig5){ref-type="fig"}; see quantification in [Figure 5B](#fig5){ref-type="fig"}), while DMSO-treated cells exhibit diffuse cytoplasmic localization of Sts5-3xGFP and Dcp1-mCherry [(Figure 5A, c, g, and k](#fig5){ref-type="fig"} and [Figure 5B](#fig5){ref-type="fig"}), supporting the idea that Orb6 kinase negatively regulates Sts5-3xGFP recruitment into RNP granules and Sts5 co-localization with P-bodies.10.7554/eLife.14216.014Figure 5.Orb6 kinase inhibits Sts5 recruitment and localization to P-bodies.(**A**) Loss of Orb6-as2 kinase activity leads to Sts5-3xGFP recruitment into puncta that colocalize with the P-body marker Dcp1-mCherry. Cells were treated with inhibitor or DMSO for 1 hr (shown) and 5 hr. Bar = 5 μm. (**B**) Quantification of three sets of experiments as shown in **A**.**DOI:** [http://dx.doi.org/10.7554/eLife.14216.014](10.7554/eLife.14216.014)

Recent work has shown that the formation of RNP granules often occurs as a result of liquid-liquid phase transition controlled by the concentration of RNP component proteins ([@bib51]; [@bib58]; [@bib21]; [@bib77]; [@bib43]; [@bib39]; [@bib7]; [@bib55]; [@bib8]; [@bib4]). To establish if Sts5 has a role in promoting P-body formation, we inhibited Orb6-as2 kinase and measured the number of Dcp1-mCherry containing granules in the presence or absence of Sts5. Interestingly, we found that the number of Dcp1-mCherry granules was significantly reduced in the *sts5∆* background, indicating that Sts5 recruitment has a role in promoting P-body formation ([Figure 6A--C](#fig6){ref-type="fig"}). We also observed residual formation of Dcp1-mCherry dots, suggesting that Orb6 kinase can induce P-body formation via Sts5-dependent as well as Sts5-independent mechanisms. Conversely, Dcp1-mCherry granules were not induced by DMSO or 1-NA-PP1 in *orb6^+^* control and *sts5∆* cells ([Figure 6---figure supplement 1A](#fig6s1){ref-type="fig"}).10.7554/eLife.14216.015Figure 6.Orb6 kinase inhibits Sts5-dependent P-body formation and translational repression.(**A**) Dcp1-mCherry localization in *orb6-as2* (**a, c**) compared with *sts5Δ orb6-as2* (**b, d**) cells grown in supplemented minimal medium in the presence of 50 μM 1-NA-PP1 (c and d) or DMSO (a and b) for 1 hr. Loss of Sts5 in the *sts5∆ orb6-as2* strain decreases the number of P-bodies induced by Orb6 kinase inhibition. Images are deconvolved projections from 12 Z-stacks separated by a step size of 0.3 μm. Bar = 5 μm. (**B**) Quantification of the experiment shown in **A** based on 3 independent experiments (n \> 24 cells per sample in each experiment). The number of P-bodies per cell was significantly lower in *sts5∆ orb6-as2* cells as compared to *orb6-as2* cells upon Orb6 kinase inhibition relative to DMSO-treated *orb6-as2* cells (*P =* 0.0186, Student's t-test). No significance difference was observed when comparing *orb6-as2* vs *sts5∆ orb6-as2* cells treated with DMSO, *P *= 0.2458 (Student's t-test). Error bars indicate SD. (**C**) Quantification of the experiment shown in **A** based on 3 independent experiments (n \> 24 cells per sample in each experiment). The total P-body fluorescence intensity per cell was significantly lower in *sts5∆ orb6-as2* cells as compared to *orb6-as2* cells upon Orb6 kinase inhibition relative to DMSO-treated *orb6-as2* cells (*P *= 0.0013, Student's t-test). No significance difference was observed when comparing *orb6-as2* vs *sts5∆ orb6-as2* cells treated with DMSO (*P *= 0.1837, Student's t-test). Error bars indicate SD. (**D**) mRNA levels of Sts5-regulated transcripts decrease upon Orb6-as2 kinase inhibition as compared to control, as established by qPCR analysis based on 3 independent experiments. *act1* is shown as an example of a transcript that is not altered. Housekeeping genes were *nda3, cdc2*, and *cdc22*. Error bars indicate SD. (**E**) Ssp1-HA protein levels in control, *orb6-as2, sts5Δ*, and *sts5Δ orb6-as2* cells cultured in the presence of 50 μM 1-NA-PP1 inhibitor in supplemented minimal medium at 25°C. Tubulin levels were determined as a loading control. (**F**) Quantification of Ssp1-HA/Tubulin in 4 independent experiments, as shown in **E**, normalized to wild-type levels. Ssp1-HA levels are significantly reduced upon Orb6-as2 kinase inhibition (*P *= 0.031), and are restored to wild-type levels in the *sts5∆ orb6-as2* strain (*P *= 0.023). P values were determined using analysis of variance (ANOVA) with SPSS statistics package 22.0, followed by Games-Howell test. Error bars indicate SD.**DOI:** [http://dx.doi.org/10.7554/eLife.14216.015](10.7554/eLife.14216.015)10.7554/eLife.14216.016Figure 6---figure supplement 1.Orb6 kinase inhibits Sts5-dependent translational repression.(**A**) Treatment with DMSO and 1-NA-PP1 does not induce P-body formation in control and *sts5Δ* cells. Dcp1-mCherry localization in control (a, c) compared with *sts5Δ* (b, d) cells grown in supplemented minimal medium in the presence of 50 μM 1-NA-PP1 (c and d) or DMSO (a and b) for 1 hr. Images are deconvolved projections from 12 Z-stacks separated by a step size of 0.3 μm. Bar = 5 μm. (**B**) Temperature-sensitive inactivation of Orb6-25 kinase promotes Sts5-dependent mRNA degradation. Decreased mRNA levels in *orb6-25* cells growth at 36°C as compared with wild type as confirmed by qPCR for a selected group of mRNAs, which were identified by microarray analysis ([Figure 3---source data 1](#SD1-data){ref-type="supplementary-material"}). (**C**) Western blots showing levels of Ssp1-HA protein in *orb6-25* and control cells at 25°C and at 36°C. Tubulin levels were determined as a loading control. (**D**) Quantification of Ssp1-HA/Tubulin ratio in the experiment shown in C, normalized to wild-type levels, based on 3 independent experiments. At the restrictive temperature (36°C), the change in Ssp1-HA level is significantly reduced in *orb6-25* as compared to control cells (*P *= 0.044). Ssp1-HA levels are significantly higher in *sts5Δ (P*\<0.0001) and *sts5Δ orb6-25 (P*\<0.0001) cells as compared to *orb6-25* cells at 36°C. P values were determined using analysis of variance (ANOVA) with SPSS statistics package 22.0, followed by Dunnet's t test. Error bars denote SD. (**E**) Western blot showing levels of Myc-Efc25 protein in *WT, sts5Δ, orb6-as2*, and *sts5Δ orb6-as2* strains cultured in the presence of 50 μM 1-NA-PP1 inhibitor in supplemented minimal medium at 25°C. Tubulin levels were determined as a loading control. Right panel: Quantification of Myc-Efc25/Tubulin ratio, normalized to wild-type levels, based on 3 independent experiments. Myc-Efc25 level is significantly reduced in *orb6-as2* as compared to control cells (*P *= 0.0048). When comparing *orb6-as2* with *sts5Δ orb6-as2* cells, *P*\<0.0001. Myc-Efc25 levels are significantly higher in *sts5Δ (P *= 0.0010) and *sts5Δ orb6-as2 (P*\<0.0140) cells compared to wild-type cells. P values were determined using analysis of variance (ANOVA) with SPSS statistics package 22.0, followed by Tukey's HSD post-hoc test. Error bars = SD.**DOI:** [http://dx.doi.org/10.7554/eLife.14216.016](10.7554/eLife.14216.016)10.7554/eLife.14216.017Figure 6---figure supplement 2.Overexpression of Orb6 inhibits Sts5 granule assembly, and Sts5 plays a role in P-body formation.(**A**) Overexpression of Orb6 reduces the intensity of Sts5-3xGFP (*P *= 0.0227, Student's t-test) and Dcp1-mCherry (*P *= 0.0352, Student's t-test) puncta in cells cultured in supplemented minimal medium minus glucose for 1 hr.Quantification based on 3 independent experiments (N\>22 cells per condition). Bar = 5 μm. (**B**) Dcp1-mCherry localization in control (**a**) compared with *sts5Δ* (**b**) cells grown in supplemented minimal medium in the presence of 0.01% glucose or 2% glucose for 1 hr. Loss of Sts5 decreases the total intensity of P-bodies induced by glucose deprivation. Bar = 5 μm. (**C**) Quantification of the number of P-bodies in the experiment shown in **B** based on 3 independent experiments relative to control cells cultured in 2% glucose. Error bars indicate SD. (N \> 29 cells per condition). (**D**) Quantification of the total P-body intensity in the experiment shown in **B** based on 3 independent experiments relative to control cells cultured in 2% glucose. Error bars indicate SD. The total P-body intensity per cell was significantly lower in *sts5∆* cells as compared to control cells upon 1 hr of growth in supplemented minimal medium containing 0.01% glucose relative to control cells (*P =* 0.0069, Student's t-test; N \> 74 cells per strain). The total P-body intensity was not significantly different among the two strains in 2% glucose (*P *= 0.8475, Student's t-test; N\>29 cells per strain). Error bars indicate SD.**DOI:** [http://dx.doi.org/10.7554/eLife.14216.017](10.7554/eLife.14216.017)

To test the role of Orb6 kinase in preventing the degradation of Sts5-regulated mRNAs, qPCR analysis was performed to probe the levels of specific transcripts following Orb6-as2 kinase inhibition with 1-NA-PP1. We found that mRNA levels of *ssp1, efc25* and *psu1* declined upon Orb6 kinase inhibition ([Figure 6D](#fig6){ref-type="fig"}). Consistent with the idea that Orb6 kinase prevents degradation and translational repression of Sts5-regulated mRNAs, immunoblotting analysis showed that Ssp1-HA protein levels decrease in *orb6-as2* cells upon inhibition with 1-NA-PP1 ([Figure 6E,F](#fig6){ref-type="fig"}). Normal Ssp1-HA protein levels were maintained in *sts5∆ orb6-as2* cells upon inhibition of Orb6-as2 kinase, in accordance with the findings that *sts5* suppresses the viability phenotype of *orb6* mutants and *sts5Δ* cells accumulate *ssp1* mRNA. These observations held true also for Ssp1-HA protein levels in temperature-sensitive *orb6-25* cells cultured at the non-permissive temperature (36°C) in the presence and absence of Sts5 ([Figure 6---figure supplement 1B--D](#fig6s1){ref-type="fig"}). Similarly to Ssp1-HA, Myc-Efc25 protein levels also declined in *orb6-as2* mutants grown in the presence of 1-NA-PP1 ([Figure 6---figure supplement 1E](#fig6s1){ref-type="fig"}), and *sts5Δ* abolished the reduction of Efc25 levels in *orb6-as2* mutants ([Figure 6---figure supplement 1E](#fig6s1){ref-type="fig"}).

Finally, we tested if Orb6 kinase over-expression alters Sts5 recruitment and P-body formation following glucose deprivation. Indeed, we found that cells over-expressing Orb6 kinase display significantly smaller Sts5- and Dcp1-containing particles than control cells, following growth for 1 hr in minimal medium without glucose ([Figure 6---figure supplement 2A](#fig6s2){ref-type="fig"}). Further, consistent with Sts5 having a role in promoting, at least in part, P-body formation during nutritional stress we found that *sts5∆* cells form significantly smaller and dimmer Dcp1-containing P bodies, as compared to control cells, following 1 hr growth in glucose deprivation conditions (shift from 2% to 0.01% glucose) ([Figure 6---figure supplement 2B--D](#fig6s2){ref-type="fig"}).

Together, these findings support the idea that Orb6 kinase prevents Sts5 recruitment to Dcp1-containing granules and attenuates P-body formation, in a manner that is at least in part Sts5-dependent. Additionally, the function of Orb6 kinase activity has the effect of decreasing the degradation of specific mRNAs.

14-3-3 protein Rad24 negatively regulates Sts5 recruitment into cytoplasmic puncta {#s2-5}
----------------------------------------------------------------------------------

We performed an in-vitro kinase assay by purification of Orb6 kinase regulatory subunit Mob2, as previously reported ([@bib107]; [@bib18], [@bib17]), using bacterially expressed Sts5. We found that the immunoprecipitate readily phosphorylates Sts5 ([Figure 7A](#fig7){ref-type="fig"}), suggesting that Orb6 kinase phosphorylates Sts5. Sts5 contains several putative NDR kinase consensus sequences ([@bib32]; [@bib68]; [@bib30]) that are consistent with 14-3-3 binding sites (RxxS) when phosphorylated ([@bib111]). We previously showed that 14-3-3 protein Rad24 has a role in negatively regulating another Orb6 substrate, Cdc42 GEF Gef1 ([@bib17]). In order to establish whether Sts5 may be subject to regulation by Rad24, we performed a pull-down assay to test whether Sts5 binds Rad24. This assay confirmed that Sts5-HA physically associates with Rad24-GST and not with GST alone ([Figure 7B](#fig7){ref-type="fig"}). Consistent with Rad24 negatively regulating Sts5 recruitment, we found that Sts5-3xGFP forms cytoplasmic puncta in *rad24∆* mutants even when cultured in rich medium (YE) in the presence of glucose ([Figure 7C,D](#fig7){ref-type="fig"}). This effect occurs in growth conditions where cells are not starved and P-body formation is not strongly induced in either *rad24∆* or control cells ([Figure 7C](#fig7){ref-type="fig"}). Accordingly, we found that *ssp1* mRNA levels do not significantly change in *rad24∆* mutants as compared to control cells ([Figure 7E](#fig7){ref-type="fig"}).10.7554/eLife.14216.018Figure 7.14-3-3 protein Rad24 negatively regulates Sts5 recruitment into puncta.(**A**) Orb6 kinase phosphorylates Sts5 *in vitro*. Mob2-associated Orb6 kinase was immunoprecipitated for a kinase assay as described in the Materials and Methods and incubated with bacterially expressed Sts5 in the presence of \[γ^32^P\]ATP. (**B**) Endogenously expressed Sts5-HA co-purifies with bacterially expressed GST-Rad24 but not with GST alone in a pull-down assay. Three independent experiments were performed. (**C**) Sts5-3xGFP and Dcp1-mCherry aggregation in 2% glucose YE in WT vs *rad24Δ* cells. Images are deconvolved projections from 12 Z-stacks separated by a step size of 0.3 μm. Bar = 5 μm. (**D**) Quantification of the experiment shown in **C** based on 3 independent experiments (n \> 27 cells per strain in each experiment). The number of Sts5 particles is significantly higher in *rad24∆* relative to wild-type control cells (*P *= 0.0005, Student's t-test). Error bars indicate SD. (**E**) qPCR analysis showing *ssp1* mRNA levels are unchanged in *rad24∆* cells compared with WT (*P *= 0.160) and increased in *sts5∆* cells compared with WT (*P *= 0.044). When comparing *sts5∆* with *rad24∆* cells, *P*=0.006. P values were determined using analysis of variance (ANOVA) with SPSS statistics package 22.0, followed by Games-Howell post-hoc test. Housekeeping genes were *nda3, act1*, and *cdc2*. Error bars indicate SD. Three independent experiments were performed. (**F**) Physical association between endogenously expressed Sts5-HA and bacterially expressed GST-Rad24 is lower upon inhibition of Orb6-as2 with 50 μM 1-NA-PP1 compared with DMSO treatment (lanes 7 and 8). Sts5-HA association with GST-Rad24 remains unchanged in wild-type cells in the presence or absence of the inhibitor (lanes 5 and 6). GST-only control is shown in lanes 1--4.**DOI:** [http://dx.doi.org/10.7554/eLife.14216.018](10.7554/eLife.14216.018)10.7554/eLife.14216.019Figure 7---figure supplement 1.Quantification of the physical association between endogenously expressed Sts5-HA and bacterially expressed GST-Rad24.Quantification of pull-down experiment depicted in [Figure 5D](#fig5){ref-type="fig"} showing a significant reduction (*P *= 0.0025; Student's t test) in the physical interaction between endogenously expressed Sts5-HA and bacterially expressed GST-Rad24 upon inhibition of Orb6-as2 kinase with 50 μM 1-NA-PP1. Error bars denote SD. Three independent experiments were performed.**DOI:** [http://dx.doi.org/10.7554/eLife.14216.019](10.7554/eLife.14216.019)

Finally, we tested the effects of Orb6 kinase activity inhibition on the association of Rad24 to Sts5. We found that that Sts5-3xGFP association with GST-Rad24 is abrogated by inhibition of Orb6-as2 kinase activity following exposure of *orb6-as2* cells to 1-NA-PP1, and not in *orb6-as2* cells exposed to DMSO or in control *orb6^+^* cells ([Figure 7F](#fig7){ref-type="fig"}; see quantification in [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}). Collectively, our findings indicate that Sts5 protein associates with 14-3-3 protein Rad24 in a manner that is dependent on Orb6 kinase activity, and that this association prevents Sts5 coalescence into cytoplasmic puncta.

Active Orb6 kinase localization spatially anti-correlates with Sts5 recruitment into puncta in interphase cells {#s2-6}
---------------------------------------------------------------------------------------------------------------

Orb6 kinase localization is enriched at the growing cell tips during interphase, in a manner that depends on the pattern of growth of the cell ([Figure 8A](#fig8){ref-type="fig"}; [Figure 8---figure supplement 1A,a,b,c and B](#fig8s1){ref-type="fig"}) ([@bib101]). In smaller cells, which grow in a monopolar manner (M), Orb6 kinase localization is higher at the old growing end and lower at the non-growing new end ([Figure 8A](#fig8){ref-type="fig"}, [Figure 8---figure supplement 1A,a](#fig8s1){ref-type="fig"}). To establish whether Orb6 kinase has a role in spatially controlling Sts5 in interphase cells during exponential cell growth, we tested the extent of Sts5 recruitment into small granules in smaller, monopolar cells (9.1 μm on average), which grow from the old end only. As shown earlier (See [Figure 2A](#fig2){ref-type="fig"}), during growth in rich medium, Sts5 localization is generally diffuse. However, a closer inspection indicated that most cells contain a few small Sts5 puncta ([Figure 8B](#fig8){ref-type="fig"}). We consistently found an increase in the number and intensity of Sts5 puncta at the non-growing end of smaller cells ([Figure 8C](#fig8){ref-type="fig"}; [Figure 8---figure supplement 1A,d,e and f](#fig8s1){ref-type="fig"}; [Figure 8---figure supplement 1B](#fig8s1){ref-type="fig"}), indicating an inverse correlation between Orb6 kinase localization at the growing tip and Sts5 aggregation ([Figure 8A--C](#fig8){ref-type="fig"}).10.7554/eLife.14216.020Figure 8.Role of Orb6 kinase in Sts5 granule assembly during the cell cycle.(**A**--**F**) Active Orb6 kinase localization spatially anti-correlates with Sts5 recruitment into puncta in interphase cells. A. Orb6-GFP localizes to the growing cell tip in small monopolar wild-type cells. Orb6-GFP is enriched at the growing old cell end as compared to the non-growing new cell end. Bar = 5 μm. (**B**) Sts5-3xGFP aggregation increases towards the new cell end in monopolar wild-type cells. Images are deconvolved projections from 12 Z-stacks separated by a step size of 0.3 μm. Bar = 5 μm. (**C**) The average number of Sts5-3xGFP puncta per cell at the non-growing new end is significantly higher as compared to the growing old end (*P*\<0.0001, Student's t-test). Error bars denote SD. Three independent experiments were performed (N = 31 cells). (**D**) Orb6-GFP localizes to the growing cell tip in *tea1∆* cells. Bar = 5 μm. (**E**) Sts5-3xGFP recruitment onto puncta increases towards the non-growing tip in *tea1∆* cells. Images are deconvolved projections from 12 Z-stacks separated by a step size of 0.3 μm. Bar = 5 μm. (**F**) The average number of Sts5-3xGFP puncta per cell at the non-growing end in *tea1∆* cells is significantly higher as compared to the growing old end (*P*\<0.0009, Student's t-test). Error bars denote SD. Three independent experiments were performed (N = 24 cells). We used calcofluor staining to identify growing tips and measured monopolar *tea1∆* cells that were growing from the previous old end, which facilitated definitive identification of the nongrowing cell end. (**G**--**H**) Orb6 kinase activity temporally anti-correlates with Sts5 assembly into puncta during mitosis. (**G**) (a, b and c) Localization of Sts5-3xGFP in cells undergoing cell division; (d, e and f) visualization of Rlc1-Tomato; (g, h and i) calcofluor staining of cell wall and septum. Bar = 5 μm. (**H**) Quantification of the number of Sts5 puncta in dividing cells during cytokinetic ring formation, ring constriction, and septation. Ring formation vs septation, *P*\<0.0001; ring constriction vs septation, *P*\<0.0001; ring formation vs ring constriction *P *= 0.588 (N\>20 cells per condition). P values were determined using analysis of variance (ANOVA) with SPSS statistics package 22.0, followed by Tukey's HSD post-hoc test. Three independent experiments were performed.**DOI:** [http://dx.doi.org/10.7554/eLife.14216.020](10.7554/eLife.14216.020)10.7554/eLife.14216.021Figure 8---figure supplement 1.Additional images of Orb6-GFP and Sts5-3xGFP localization in monopolar WT cells and quantification of total Sts5-3xGFP granule intensity at growing and nongrowing tips.(**A**) (**a, b, c**) Localization of Orb6-GFP in wild-type monopolar (M) (**a**), bipolar (B) (**b**), and septated (S) (**c**) cells cultured in supplemented minimal medium. (**d, e, f**) Localization of Sts5-3xGFP puncta (see arrows) in wild-type monopolar (M) cells (**d, e, f**). \* indicates growing tip. Bar = 5 μm. (**B**) The average total intensity per cell of Sts5-3xGFP puncta at the non-growing new end is significantly higher as compared to the growing old end (P = 0.0059, Student's t-test). Error bars denote SD. Three independent experiments were performed (N = 31 cells).**DOI:** [http://dx.doi.org/10.7554/eLife.14216.021](10.7554/eLife.14216.021)10.7554/eLife.14216.022Figure 8---figure supplement 2.Additional images of Orb6-GFP and Sts5-3xGFP localization in monopolar *tea1Δ* cells and quantification of total Sts5-3xGFP granule intensity at growing and nongrowing tips.(**A**) (**a**) Localization of Orb6-GFP in *tea1Δ* monopolar cells, and (**b--f**) localization of Sts5-3xGFP puncta (see arrows) in *tea1Δ* monopolar cells cultured in supplemented minimal medium. \* indicates growing tip. Bar = 5 μm. (**B**) The average total intensity per cell of Sts5-3xGFP puncta at the non-growing end in *tea1∆* cells is significantly higher as compared to the growing old end (*P *= 0.0435, Student's t-test). Error bars denote SD. Three independent experiments were performed (N = 24 cells).**DOI:** [http://dx.doi.org/10.7554/eLife.14216.022](10.7554/eLife.14216.022)10.7554/eLife.14216.023Figure 8---figure supplement 3.Orb6 kinase inhibition prevents the dissolution of Sts5-3xGFP puncta after completion of mitosis.(**A**) (**a, b, c**) Localization of Sts5-3xGFP in cells undergoing cell division and (**d, e, f**) expressing Rlc1-Tomato during cytokinetic ring formation, ring constriction, and septation in *orb6-as2* cells treated with DMSO. Bar = 5 μm. Right panel: Quantification of Sts5-3xGFP puncta in DMSO-treated *orb6-as2* cells. Ring formation vs septation, *P*\<0.0001; ring constriction vs septation, *P*\<0.0001; ring formation vs ring constriction *P *= 0.345 (N = 18 cells per condition). P values were determined using analysis of variance (ANOVA) with SPSS statistics package 22.0, followed by Tukey's HSD post-hoc test. Three independent experiments were performed. (**B**) (**a, b, c**) Localization of Sts5-3xGFP in cells undergoing cell division and (**d, e, f**) expressing Rlc1-Tomato during cytokinetic ring formation, ring constriction, and septation in *orb6-as2* cells treated with 50 mM 1-NA-PP1 for 1 hr. Bar = 5 μm. Right panel: Quantification of Sts5-3xGFP puncta in 1-NA-PP1-treated *orb6-as2* cells. Ring formation vs septation, *P *= 0.764; ring constriction vs septation, *P*\<0.773; ring formation vs ring constriction *P *= 0.392 (N = 18 cells per condition). P values were determined using analysis of variance (ANOVA) with SPSS statistics package 22.0, followed by Tukey's HSD post-hoc test. Three independent experiments were performed.**DOI:** [http://dx.doi.org/10.7554/eLife.14216.023](10.7554/eLife.14216.023)10.7554/eLife.14216.024Figure 8---figure supplement 4.*sts5∆* cells display increased cell lysis during cell separation.(**A**) *sts5∆* cells display increased cell lysis during cell separation (**d**) at the restrictive temperature (35.5°C). Arrows indicate sister cells that have lysed. (**B**) Quantification of the percentage of septated cells that lyse in WT and *sts5∆* cells at 25°C and 35.5°C. Quantification based on 3 independent experiments. Percentage of septated cells that lyse is significantly greater in *sts5Δ* cells as compared to controls at 35.5°C (*P *= 0. 0.0022, Student's t-test, N\>176 cells per condition). When comparing WT and *sts5∆* cells 25°C, *P *= 0.1583 (Student's t-test).**DOI:** [http://dx.doi.org/10.7554/eLife.14216.024](10.7554/eLife.14216.024)

To further investigate this effect, we visualized Sts5-3xGFP in longer *tea1∆* cells that grow from one end only ([@bib88]; [@bib100]). t*ea1Δ* cells display monopolar Orb6-GFP localization at the only growing cell tip ([Figure 8D](#fig8){ref-type="fig"}; [Figure 8---figure supplement 2A,a](#fig8s2){ref-type="fig"}). In these cells, Sts5-3xGFP recruitment into small puncta was clearly seen increasing towards the non-growing cell tip ([Figure 8E-F](#fig8){ref-type="fig"}; [Figure 8---figure supplement 2A,b--f](#fig8s2){ref-type="fig"}; [Figure 8---figure supplement 2B](#fig8s2){ref-type="fig"}: asterisk marks the growing tip).

Collectively, our findings indicate that Orb6 kinase activity negatively regulates Sts5 recruitment into cytoplasmic puncta, via interaction with 14-3-3 protein Rad24, in a manner that is spatially significant: an asymmetry of Orb6 distribution between growing and non-growing tips correlates with an asymmetry in Sts5 recruitment.

Role of Orb6 kinase in the control of Sts5 during cell separation {#s2-7}
-----------------------------------------------------------------

Orb6 kinase activity is repressed during mitosis by the septation-initiation network (SIN), which triggers cytokinesis ([@bib42]; [@bib29], [@bib28]). SIN signaling remains active until completion of cytokinesis, which is marked by closure of the contractile ring and a fully formed cell septum ([@bib26]; [@bib2]). After cytokinesis, the primary septum must be degraded for cell separation to occur. The derepression of MOR signaling, and of Orb6 activity, that results from inactivation of the SIN pathway promotes cell separation upon completion of cytokinesis ([@bib28]). Consistent with Orb6 kinase re-activation, Sts5-3xGFP puncta dissipate when the septum is fully closed and the actomyosin contractile ring protein Rlc1, encoding myosin II regulatory light chain ([@bib54]; [@bib110]), disappears from the plane of cell division ([Figure 8G,H](#fig8){ref-type="fig"}; [@bib106]). Orb6-GFP is still physically present at the site of cell division during septum formation and cytokinetic ring constriction ([Figure 8---figure supplement 1A,c](#fig8s1){ref-type="fig"}) while it is enzymatically repressed by SIN signaling ([@bib42]; [@bib29], [@bib28]; [@bib26]; [@bib2]). Consistent with a role for Orb6 kinase reactivation in mediating Sts5-3xGFP granules dissipation, Orb6 kinase inhibition maintains Sts5-3xGFP granules even following actin ring closure and Rlc1 disappearance ([Figure 8---figure supplement 3A,B](#fig8s3){ref-type="fig"}).

Supporting a role for Orb6 kinase and its substrate target Sts5 in cell separation, microarray analysis found that Sts5 negatively regulates transcripts that encode cell wall proteins with potential functions in cell separation. Transcripts for a predicted β-1,3 glucanase (encoded by SPBP23A10.11C) and predicted β-glucosidase Psu2 are more abundant in *sts5Δ* cells (See [Figure 3---source data 1](#SD1-data){ref-type="supplementary-material"}), consistent with a role for β-1,3 glucan degradation in the primary septum during the process of cell separation ([@bib65]). In addition, *sts5Δ* cells accumulate transcripts of the transcription factor Mbx1 (See [Figure 3---source data 1](#SD1-data){ref-type="supplementary-material"}) that cooperates with the transcription factor Ace2 to promote expression of endo-glucanase Agn1, a hydrolytic enzyme involved in septum degradation ([@bib91]).

Thus, it is possible that Sts5 recruitment into puncta during mitosis, mediated by SIN pathway-dependent inhibition of Orb6 kinase, functions to translationally repress mRNAs encoding cell wall hydrolytic enzymes that would interfere with the deposition of the primary septum. Consistent with this idea, we found that *sts5∆* cells are prone to rupture at the site of cell separation ([Figure 8---figure supplement 4A,d and B](#fig8s4){ref-type="fig"}) similarly to cells that express ectopically active Orb6 during mitosis ([@bib29], [@bib28]).

Sts5 restrains bipolar growth activation during exponential cell proliferation and during nutritional stress {#s2-8}
------------------------------------------------------------------------------------------------------------

When cultured at 25°C, *sts5Δ* cells appear normal with a cylindrical shape ([@bib96]). However, we found that *sts5Δ* cell cultures display an increased percentage of cells growing in a bipolar fashion, as compared to similarly sized control cells, under exponential growth conditions (optical density at 595 nm \<0.4) in both rich ([Figure 9A,B](#fig9){ref-type="fig"}) as well as in minimal medium ([Figure 9---figure supplement 1A](#fig9s1){ref-type="fig"}). These findings suggest that Sts5 has a function in partially constraining growth at the new end during the exponential growth phase (OD\<0.4), without affecting overall growth rates ([Figure 9---figure supplement 1B](#fig9s1){ref-type="fig"}) or cell length at division, which are the same as control cells ([Figure 9C](#fig9){ref-type="fig"}).10.7554/eLife.14216.025Figure 9.Sts5 modulates bipolar growth activation during exponential cell proliferation and during nutritional stress.(**A**) *sts5∆* cells display a delayed morphological response to nutritional stress induced by high cell density as compared with wild type cells. Cells were stained with calcofluor. Bar = 5 μm. (**B**) Quantification of the percentage of bipolar cells in control versus *sts5∆* cells in the experiment depicted in **A**. Percentage bipolar cells was significantly higher in *sts5∆* cells versus control cells during exponential growth (OD~600~ \<0.4) (*P *= 0.0013, Student's *t* test) and at OD~600~ = 1.4 (*P*\<0.0001, Student's *t* test), OD~600~ = 3 (*P*\<0.0001, Student's t test), and OD~600~ = 4.5 (*P *= 0.0003, Students' t test). Error bars indicate SD. At least 3 independent experiments were performed (N\>64 for each strain per cell density condition). Cells undergoing cell division were not included. (**C**) Quantification of cell size (defined as cell length at division) in control versus *sts5∆* cells in the experiment depicted in A. Cell size was significantly longer in *sts5∆* cells versus control at OD~600~ = 1.4 (*P*\<0.0001, Student's *t* test), OD~600~ = 3 (*P*\<0.0001, Student's t test), and OD~600~ = 4.5 (*P*\<0.0001, Student's t test). Error bars indicate SD. At least 3 independent experiments were performed (N\>16 for each strain per cell density condition).**DOI:** [http://dx.doi.org/10.7554/eLife.14216.025](10.7554/eLife.14216.025)10.7554/eLife.14216.026Figure 9---figure supplement 1.Increased bipolarity of *sts5Δ* vs wild-type cells is not due to changes in cell size or overall cell growth.(**A**) Quantification of the percentage of bipolar cells in wild type versus *sts5∆* cells comparing small cells (\<10 mm in length; *P *= 0.0050, Student's t-test), larger cells (10--11.99 mm in length; *P *= 0. 0.0012 Student's t-test) and cell with a length longer than 12 µm cells; *P = *0.0256).Quantifications based on 4 independent experiments (N\>239 cells per strain). (**B**) Growth curves (OD 595 nm) of wild-type versus *sts5∆* cells as measured by the TECAN system. Cell were grown in supplemented minimal medium.**DOI:** [http://dx.doi.org/10.7554/eLife.14216.026](10.7554/eLife.14216.026)

Since the pattern of cell growth is altered by nutritional stress, inhibiting bipolar growth activation and increasing the percentage of monopolar cells, ([@bib90]; [@bib114]; [@bib113]) we hypothesized that Sts5 recruitment into puncta, a form of RNP granules, might have an adaptive role to modulate the morphological response during nutritional starvation. As cell density increases, *S. pombe* cells respond to limiting nutrient availability by entering mitosis at a shorter cell size ([@bib15]; [@bib90]; [@bib114]; [@bib113]). We found that, whereas wild-type cells divide at a shorter length upon starvation induced by high cell concentration, as determined by optical absorbance at 595 nm ([Figure 9](#fig9){ref-type="fig"}), *sts5Δ* cells maintain a longer length at cell division as cell concentration increases ([Figure 9A,C](#fig9){ref-type="fig"}). Similarly, a higher proportion of *sts5Δ* mutants continue to activate bipolar growth, as compared to wild-type cells at the same concentration ([Figure 9B](#fig9){ref-type="fig"}). These observations suggest that Sts5 has a role in partially constraining bipolar cell growth, a function that is important for cellular adaptation to nutrient limitation. Consistent with this idea, we find that *sts5∆* cells display decreased viability after prolonged starvation (I.N. and F.V., unpublished observation).

Collectively, our results indicate that NDR kinase Orb6 inhibits the recruitment of mRNA-binding protein Sts5 into cytoplasmic puncta by promoting its interaction with 14-3-3 protein Rad24. Further, Orb6 kinase has a role in negatively controlling P-body formation, in a manner that is at least in part Sts5-dependent. This mechanism controls the levels of mRNAs encoding proteins important for polarized cell growth and cell separation. During interphase, Orb6 inhibits Sts5 recruitment in a manner that is biased towards the old end in small cells, thus promoting normal cell morphogenesis and partially constraining extensile growth at the second, newer cell tip. Extensive Sts5 recruitment into smaller puncta during mitosis and into larger RNP granules during nutritional stress may allow proper septum deposition and modulates morphological adaptation to limiting nutrient availability.

Discussion {#s3}
==========

In this article, we define a novel mechanism that spatially regulates polarized cell growth and cell morphology in fission yeast during exponential cell proliferation and in response to environmental stressors, such as increased temperature or cell density. Under exponential growth conditions, fission yeast grow in a monopolar fashion during early interphase and activate growth at the new cell tip once a minimal cell length has been achieved. Different control mechanisms cooperate in the activation of the second tip, a process known as NETO (New End Take Off), including the microtubule-dependent Tea1 complex ([@bib63]; [@bib85]; [@bib64]; [@bib95]), the availability of Cdc42 regulators ([@bib12]; [@bib94]; [@bib16]), cell transcription ([@bib102]), and a diverse array of signaling kinases ([@bib50]; [@bib67]; [@bib84]; [@bib49]; [@bib27]). We have previously shown that NDR kinase Orb6 promotes cell polarity and regulates bipolar growth by spatially restricting the activation of Cdc42 GTPase, a key morphology control factor ([@bib18]). We recently showed that Orb6 negatively regulates Cdc42 activation by promoting the association of Cdc42 Guanine Exchange Factor (GEF) Gef1 with 14-3-3 protein Rad24, and thus limiting Gef1 activity at the membrane ([@bib17]). This function has the effect of spatially regulating Cdc42 activation, thus promoting the emergence of cell polarity.

In this article, we describe a genetically separable role for Orb6 kinase in the control of polarized cell growth and cell separation. We report that Orb6 kinase regulates the association of mRNA-binding protein Sts5, another Orb6 substrate target, with 14-3-3 protein Rad24. This association prevents the recruitment of Sts5 into cytoplasmic puncta (see hypothetical model in [Figure 10A](#fig10){ref-type="fig"}). Orb6 localization varies during the cell cycle, increasing at the cell tips during interphase and at the cell septum during cell division ([@bib101]; [@bib107]). In small cells that have not yet undergone NETO, or in the monopolar *tea1Δ* mutant cells, Orb6 is enriched at the one growing cell tip. Consistent with a role for Orb6 in inhibiting Sts5 assembly into puncta, we have observed that Sts5-3xGFP puncta are spatially anti-correlated with Orb6 kinase activity and are preferentially localized near non-growing cell tips, which are depleted of Orb6 kinase ([Figure 10B](#fig10){ref-type="fig"}). Because Orb6 kinase is enriched at growing cell tips, this method of Sts5 regulation might promote the availability of Sts5-targeted mRNAs for translation near sites of polarized growth, while partially constraining growth at the non-growing, newer cell tip. Consistent with this idea, an increased percentage of *sts5Δ* cells exhibit a bipolar pattern of growth, as compared to control cells of similar length.10.7554/eLife.14216.027Figure 10.A model of spatial control of translational repression and polarized growth by Orb6 kinase and mRNA binding protein Sts5.(**A**) Orb6 kinase prevents Sts5 recruitment into larger RNP granules by promoting the association between Sts5 and the 14-3-3 protein Rad24. Upon Orb6 kinase inhibition, Sts5 proteins are recruited into larger RNP granules and co-localize with P-bodies, leading to reduced mRNA levels and translational repression. (**B**) In small monopolar cells Orb6 kinase is localized at the growing old end. Sts5 recruitment in larger granules is observed at the new end, lacking Orb6 kinase activity. In larger bipolar cells Orb6 kinase is localized at both cell tips, and Sts5 recruitment is reduced at both cell ends and throughout the cell. During mitosis, Orb6 kinase is inactivated by the SIN pathway, which allows Sts5 recruitment into larger RNP granules and translational repression. Once cell separation is complete, Orb6 kinase activity resumes, promoting Sts5 disassembly, translational derepression, and cell separation.**DOI:** [http://dx.doi.org/10.7554/eLife.14216.027](10.7554/eLife.14216.027)

By microarray and qPCR analysis we found that several transcripts, previously implicated in bipolar growth activation, accumulate in *sts5Δ* cells. These transcripts encode the putative CAMK kinase Cmk2, CAMKK kinase Ssp1, LAMMER kinase Lkh1, pseudokinase Tea5/Ppk2, and PDK1 kinase Ksg1, which promote bipolar growth activation in *S. pombe* ([@bib50]), as well as the Ras1 GEF Efc25, which affects Cdc42 activity ([@bib75]). In higher eukaryotes, the homologues of these Sts5-regulated transcripts are also implicated in cell growth and morphology. CAMK signaling regulates cytoskeletal organization, plays a role in neuronal development and dendritic spine morphology, and has been shown to be increased in mouse models of cardiac hypertrophy ([@bib78]; [@bib76]). The *Drosophila* LAMMER kinase Doa inhibits proliferation of germ cells ([@bib118]). Also, Ras signaling has conserved roles in cytoskeletal organization with implications for cancer development ([@bib87]). Activation of PI3K signaling via PDK1 kinase has been implicated in cancer, and PDK1 has been found to regulate cell growth, proliferation, and migration ([@bib57]; [@bib72]).

Consistent with Orb6 kinase inhibiting the extent of Sts5 recruitment during exponential growth, Sts5-containing cytoplasmic puncta assemble during the later stages of mitosis when Orb6 kinase activity is blocked by the SIN pathway ([Figure 10B](#fig10){ref-type="fig"}) ([@bib99]; [@bib29], [@bib28]). Sts5 recruitment during cytokinesis may function to prevent inappropriate translation of proteins involved in septum degradation while the septum is still forming. Indeed, *sts5∆* cells lyse at the cell septum, in particular upon stress. Once cytokinesis is complete and Orb6 kinase is once again active, Sts5 localization is again diffuse in the cytoplasm, perhaps to allow expression of hydrolases required for cell separation. Consistent with this idea, *orb6* mutants delay cell separation. We did not find obvious induction of P-body formation during mitosis or interphase, likely preventing the degradation of Sts5-regulated transcripts that will eventually be needed for cell separation and polarized cell growth. This result suggests that P-body independent, Sts5-containing RNPs are formed during mitosis and that additional stress signals are required for Sts5 to seed P-body formation under nutritional limitation conditions.

Sts5 bears closest homology to RNA exonucleases such as fission yeast Dis3L2 ([@bib61]). In humans, hDis3L2 is of particular interest because it has been implicated in the congenital Perlman syndrome, which confers fetal overgrowth and susceptibility to Wilms tumor ([@bib3]). Whereas Sts5 lacks crucial amino acids required for exonuclease activity ([Figure 1C](#fig1){ref-type="fig"}) ([@bib61]; [@bib98]), our work shows that Sts5 promotes mRNA degradation likely by promoting the interaction of Sts5-associated transcripts with P-body components. Similar to Sts5, Dis3L2 also localizes to P-bodies ([@bib61]), as well as the *S. cerevisiae* homologue of Sts5, Ssd1 ([@bib40]; [@bib52]). These findings suggest that, differently from the related exonuclease Dis3 ([@bib82]), this group of RNA-binding proteins employs a mechanism of mRNA degradation that does not involve interaction with the exosome. However, it is likely that Sts5 and Dis3L2 have different roles in P-body assembly and/or recruitment of mRNAs to P-bodies. Indeed, deletion of the *sts5* homologue *dis3L2* does not suppress the growth defect observed upon Orb6-as2 kinase inhibition ([Figure 1---figure supplement 2B](#fig1s2){ref-type="fig"}). In *S. cerevisiae* and *C. albicans*, Sts5 homologue Ssd1, with roles in cell wall hydrolysis ([@bib40]; [@bib105]), fertility ([@bib6]), and transcription ([@bib56]), has been proposed to promote localized mRNA translation because of its enrichment at the bud site ([@bib52]; Lee et al., 2015). We have not observed enrichment of Sts5 at the sites of polarized growth in *S. pombe* cells, which may employ a different strategy for ensuring adequate mRNA localization in daughter cells.

Our work indicates that Sts5 may function as a seed for P-body formation under stress and upon Orb6 kinase inhibition. P-bodies and similar RNPs have been shown to have liquid properties and their formation has been described as condensation by a phase-separation mechanism once P-body components reach critical concentrations ([@bib51]; [@bib58]; [@bib21]; [@bib39]; [@bib7]; [@bib55]; [@bib8]; [@bib4]). It has been proposed that mRNA-binding proteins may play a role in the aggregation of mRNPs into larger structures, especially proteins containing intrinsically disordered domains, which have the potential to promote phase separation by forming multiple weak protein-protein interactions ([@bib58]; [@bib77]; [@bib21]; [@bib104]; [@bib43]; [@bib31]; [@bib62]; [@bib97]; [@bib51]). Thus, Sts5 may have the ability to function in mRNP granule formation through interactions with other P-body proteins, and one function of Orb6 phosphorylation may be to limit Sts5 recuitment to prevent inappropriate seeding of P-bodies. Consistent with this idea, Sts5 displays a predicted disordered domain at the N-terminus, which is phosphorylated *in vivo* ([@bib45]; [@bib10]; [@bib47]; [@bib108]). Future experiments will address how phosphorylation of this domain modulates the function of Sts5 and affects its properties *in vitro*.

We found that Sts5 has a role in the morphological response to nutritional stress. Wild type *S. pombe* cells mount characteristic morphological responses to changing environmental conditions: increased temperature ([@bib71]), decreased nutrient availability ([@bib15]; [@bib90]; [@bib114]; [@bib113]), and hyper-osmotic stress decrease the incidence of bipolar growth activation and alter overall cell dimensions ([@bib84]; [@bib81]). The mechanisms that modulate cell morphogenesis and polarized cell growth in response to varying growth and environmental conditions are still poorly understood. We find that *sts5Δ* mutants delay the adaptation to starvation conditions, maintaining bipolar growth and a longer cell length as cell density increases and the medium becomes depleted of nutrients. This effect appears to be further exacerbated at higher temperatures (36°C), where *sts5Δ* cells become enlarged and bloated, with increased protein levels of the CAMKK Ssp1. Our findings indicate that *sts5Δ* mutants have defects in adapting to nutrient deprivation or temperature increase, and fail to manifest the appropriate morphological response to varying extracellular conditions. Thus Sts5 may integrate diverse nutritional and environmental signals to coordinate changes to the pattern of cell growth.

In summary, our results support a role for NDR kinases in the spatial control of polarized cell growth, during cell proliferation and in response to the nutritional environment by mediating the translational availability of specific mRNAs. Future research will seek to identify nutrient-sensitive signaling pathways upstream of Orb6 and define the specific roles of Orb6 kinase and Sts5 in the control of P-body assembly. Due to the conservation of these factors, this work has the potential to open new avenues of research linking nutrient-sensitive signaling and P-body regulation with implications for studies of cancer and neurodegenerative diseases.

Materials and methods {#s4}
=====================

Strains and cell culture {#s4-1}
------------------------

*S. pombe* strains used in this study are listed in the supplement in [Supplementary file 1](#SD2-data){ref-type="supplementary-material"}. All strains used in this study are isogenic to the original strain 972. Cells were cultured in yeast extract (YE) medium or minimal medium (EMM) plus required supplements. Prototrophic strain FV2267 was cultured in unsupplemented EMM. For glucose and nitrogen starvation experiments, cells were washed in glucose-free or nitrogen-free EMM before transfer to EMM either lacking or containing 2% glucose or 0.5% nitrogen, respectively. Exponential growth was maintained for at least eight generations before experimental analysis, and genetic manipulations and analysis were carried out using standard techniques ([@bib73]).

Isolation of the suppressor mutants from the MOR mutants {#s4-2}
--------------------------------------------------------

Approximately 5 × 10^7^ cells of the *nak1-125* (KP1-6D), *orb6-25* (DH433-12C), or *mor2*-276 mutant (DH107-4C) were spread per one YPD plate (1% yeast extract, 2% polypeptone, 2% dextrose, and 2% agar) containing 10 mg/ml Phloxine B (Sigma-Aldrich, P2759) (called YPDP plate), and the plates were incubated at 35.5°C for 4 days. Spontaneously developed Ts+ colonies at 35.5°C were picked up on YPDP plate and incubated at 35.5°C for 3 days. To investigate the cold sensitivity and cell morphology of the mutants, the Ts+ colonies were replica plated on 2 YPDP plates and incubated at 18°C and 35.5°C. In this screening, we selected Ts+ and cold sick (red colony) at 18°C, and isolated 1, 2, or 1 *sts5* mutant alleles from *mor2, nak1*, or *orb6* mutants, respectively. Genetic linkage (allelism) between the suppressors and *sts5* was confirmed by tetrad analysis.

Fluorescence microscopy {#s4-3}
-----------------------

Cells expressing fluorescently tagged proteins were photographed using an Olympus fluorescence BX61 microscope (Melville, NY) equipped with Nomarski differential interference contrast (DIC) optics, a 100X objective (NA 1.35), a Roper Cool-SNAP HQ camera (Tucson, AZ), Sutter Lambda 10 + 2 automated excitation and emission filter wheels (Novato, CA) and a 175 W Xenon remote source lamp with liquid light guide. Images were acquired and processed using the Intelligent Imaging Innovations (Denver, CO) SlideBook image analysis software and prepared with Adobe Photoshop CC (San Jose, CA) and ImageJ64 (U. S. National Institutes of Health) (ImageJ, RRID:[SCR_003070](https://scicrunch.org/scicrunch/Resources/record/nlx_144509-1/063e0149-a929-5fd5-8968-34dff7e4fd59/search)). For measurements of Sts5-3xGFP and Dcp1-Cherry puncta, we subtracted the contribution of the cytoplasmic background for each cell as previously described ([@bib16]). This process was performed using an ImageJ plugin that sets a subtraction threshold to 3 standard deviations from cytoplasmic-region mean. Pilot studies were used to obtain means and standard deviations to be used for sample size estimation before determining how many cells to measure in each independent experiment of Sts5-3xGFP or Dcp1-mCh aggregation. The following formulas were used for sample size estimation, assuming an alpha of 0.05, beta of 0.2, and power of 0.8:

k= (n~2~/n~1~) = 1

n~1~ = \[(σ~1~^2^ + σ~2~^2^/K)(z~1\ --\ α/2~ + z~1\ --\ β~)^2^\] / Δ^2^

Δ = \|μ2-μ1\| = absolute difference between two means

σ~1~, σ~2~ = mean variances

n~1~ = group 1 sample size

n~2~ = group 2 sample size

α = probability of type I error (set to 0.05)

β = probability of type II error (set to 0.2)

z = critical Z value for a given α or β

RNA extraction (for qPCR and microarray) {#s4-4}
----------------------------------------

Cells were grown under normal conditions (eight generations of exponential growth) prior to the start of the experiment. Cells were then treated in accordance with the particular experiment. The RNA was extracted from the yeast using the ZR Fungal/Bacterial RNA MiniPrep kit (Zymo Research). After elution of the RNA, the remaining genomic DNA was digested with TURBO DNA-free (Ambion). The digestion of genomic DNA was confirmed by PCR amplification of the housekeeper genes.

qPCR analysis {#s4-5}
-------------

RNA was quantified via NanoDrop, and cDNA was prepared using the iScript cDNA Synthesis Kit (Bio-Rad). The qPCR reaction was done with SsoFast Evagreen Supermix (Bio-Rad) using primers design with Beacon in a Bio-Rad CFX96 Real-Time PCR system. Data was analyzed with Bio-Rad CFX Manager 2.0 software using a regression Cq determination mode. Our housekeeper genes were *nda3*, *act1*, *cdc2*, and *cdc22* (depending on the experiment). Each condition was run at least in triplicate and 3 independent experiments were performed.

Microarray analysis {#s4-6}
-------------------

RNA was provided to the Oncogenomics Facility (<http://sylvester.org/research/shared-resources/laboratory-resources/oncogenomics-core-facility>) for the Bioanalyzer to assess RNA quality and amount, followed by microarray hybridization and scanning using the Affymetrix GeneChip Yeast Genome 2.0 Array. Data was then analyzed with MEV (<http://www.tm4.org/mev>) (TM4 Microarray Software Suite: TIGR MultiExperiment Viewer, RRID:[SCR_001915](https://scicrunch.org/scicrunch/Resources/record/nlx_144509-1/2bce991d-52b6-58e0-a54e-be5857ae9d85/search)) after conversion to RMA via RMAExpress (<http://rmaexpress.bmbolstad.com/>) (RMA Express, RRID:[SCR_008549](https://scicrunch.org/scicrunch/Resources/record/nlx_144509-1/073f7247-8ea2-512a-b92a-109ddc4f1730/search)).

Gene ontology enrichment analysis {#s4-7}
---------------------------------

Gene ontology enrichment analysis was performed using Database for Annotation, Visualization, and Integrated Discovery (DAVID) Bioinformatics Resource 6.7 (DAVID, RRID:[SCR_001881](https://scicrunch.org/scicrunch/Resources/record/nlx_144509-1/5fb1cf22-551d-5fcf-9152-89c44e19b9e4/search)).

Immunoprecipitation of Sts5-3xGFP and identification of associated mRNAs {#s4-8}
------------------------------------------------------------------------

Cultures were grown of wild-type cells and *sts5-3xGFP* cells for harvesting. Cell pellets were broken in breaking buffer (20 mM Tris-HCl (pH 8.0), 140 mM KCl, 1.8 mM MgCl~2~, 0.1% NP-40, 0.2 mg/ ml heparin, 0.5 mM DTT, protease inhibitors (complete EDTA-free protease inhibitor cocktail tablets (Roche Applied Science)), 100 U/ml Rnasin Plus (Promega)) with a Savant FastPrep FP120 bead beater. The Sts5 protein was then immunoprecipitated with anti-GFP (Roche; RRID:[AB_390913](https://scicrunch.org/resolver/AB_390913)) and protein G magnetic resin (Invitrogen). After extensive washing of the resin with wash buffer (20 mM Tris-HCl (pH 8.0), 140 mM KCl, 1.8 mM MgCl~2~, 10% glycerol, 0.5 mM DTT, 0.01% NP-40, 10 U/ml Rnasin Plus, and protease inhibitors in the beginning washes), the RNA was eluted from the resin by treating the resin with proteinase K. The RNA was then purified with a spin column kit (ZR Fungal / Bacteria RNA MiniPrep Kit, Zymo Reseach). After elution of the RNA, the remaining genomic DNA was digested with TURBO DNAse (Ambion) and the digestion was confirmed by PCR. qPCR was then used to determine the relative levels of target mRNA in WT (null IP) versus the Sts5-3xGFP IP.

Bacterially expressed Sts5 protein purification {#s4-9}
-----------------------------------------------

Sts5 ORF (a.a. 1--1066) was tagged with N-terminal His6 by cloning into pET15b expression vector. The construct was transformed in BL21 cells, and His6-Sts5 expression was induced by incubation with 1mM IPTG for 1 hr. Native His6-Sts5 was purified using Ni-NTA spin columns (Qiagen) following the manufacturers instructions. Western blot using anti-His6 antibody (Covance; [AB_10063707](https://scicrunch.org/resolver/AB_10063707)) was performed to confirm the purification of His6-Sts5.

Mob2-associated kinase assay {#s4-10}
----------------------------

*In vitro* kinase assay for phosphorylation of Sts5 was performed as described in [@bib107]. Briefly, Myc-tagged Mob2 and untagged Mob2 were expressed in *S. pombe* cells grown to mid-log phase at 32°C. Cells lysis was performed using Savant FastPrep FP120 bead beater in HB buffer (25 mm MOPS, pH 7.2, 60 mM β-glycerophosphate, 15 mM p-nitrophenyl phosphate, 15 mM MgCl~2~ 15 mM EGTA, 1 mM dithiothreitol, 0.1 M sodium vanadate, 1% Triton X-100, 1 mM phenylmethylsulfonyl fluoride, and protease inhibitors (complete EDTA-free protease inhibitor cocktail tablets (Roche Applied Science))). Extracts from cells expressing Myc-tagged Mob2 and from wild-type cells were incubated with Protein A agarose (Sigma-Aldrich) beads bound to rabbit anti-Myc antibodies (Santa Cruz Biotechnology; RRID:[AB_631274](https://scicrunch.org/resolver/AB_631274)) for 1 hr, washed twice with HB buffer, and then washed once with kinase buffer (50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 10 mM MgCl~2~,1 mM MnCl~2~). The resin was resuspended in 25 μl of kinase buffer containing 10 μCi of \[γ-32P\]ATP (6000 Ci/mmol) and 20 μM ATP and combined with 5 μl bacterially expressed Sts5. The kinase reaction was stopped after 20 min at 30°C. Proteins were separated on an SDS polyacrylamide gel.

Western blot analysis of Ssp1-HA levels {#s4-11}
---------------------------------------

The protein extraction was performed as previously described ([@bib66]). 10-ml cultures of exponentially growing cells were harvested by centrifuging at 5000 rpm for 5 min. The cell pellet was first washed in 1 mL of distilled water and then resuspended in 300 μL of distilled water. Then, 300 μL of 0.6 M NaOH was added, and cells were incubated at room temperature for 10 min and collected by centrifugation. After removing the supernatant, cells were resuspended in modified SDS sample buffer (60 mM Tris HCl pH 6.8, 4% β-mercaptoethanol, 4% SDS, 0.01% bromophenol blue, and 5% glycerol) and boiled for 3 min. The samples were then loaded on 4--15% Mini-PROTEAN TGX gels (Biorad) for routine western analysis.

Antibodies {#s4-12}
----------

The primary antibodies used were mouse monoclonal anti-HA (Covance; RRID:[AB_2314672](https://scicrunch.org/resolver/AB_2314672)), rabbit polyclonal purified antibody c-Myc (A-14) (Santa Cruz Biotechnology, Inc.; RRID:[AB_631274](https://scicrunch.org/resolver/AB_631274)) rat monoclonal anti-α-tubulin \[YL1/2\] (Novus Biologicals; RRID:[AB_305328](https://scicrunch.org/resolver/AB_305328)), mouse monoclonal anti-α-tubulin clone B-5-1-2 (Sigma-Aldrich; [AB_477579](https://scicrunch.org/resolver/AB_477579)) and rabbit polyclonal anti-GST (Z-5) (Santa Cruz; [AB_631586](https://scicrunch.org/resolver/AB_631586)). The secondary antibodies used were IRDye 800 conjugated anti-mouse antibody (Rockland Immunochemicals, Inc; RRID: RRID:[AB_10703265](https://scicrunch.org/resolver/AB_10703265)), IRDye 800 conjugated anti-rabbit antibody (Rockland Immunochemicals, Inc; RRID:[AB_220152](https://scicrunch.org/resolver/AB_220152)), and IRDye700 conjugated anti-rat antibody (Rockland Immunochemicals Inc.; RRID: [AB_220171](https://scicrunch.org/resolver/AB_220171)). The blots were analyzed using the Odyssey Infrared Imaging system (LI-COR Biosciences).

Orb6-as2 kinase inhibition {#s4-13}
--------------------------

Design and construction of the *orb6-as2* analog-sensitive mutant was previously described ([@bib18]). Inhibition of Orb6-as2 kinase was carried out using the ATP-analog 1-NA-PP1 (4-Amino-1-tert-butyl-3-(1'-naphtyl) pyrazolo \[3,4-d\]pyrimidine; Toronto Research Chemicals) diluted in DMSO. In liquid media, a final concentration of 50 μM 1-NA-PP1 was used to achieve Orb6-as2 kinase inhibition. In solid media, the final concentration of 1-NA-PP1 used was 10 μM.

Rad24 binding assays {#s4-14}
--------------------

Bacterially expressed GST and GST-Rad24 were bound to Glutathione linked sepharose beads or magnetic beads (Pierce). The beads were then mixed with fission yeast protein extract from wild type and Sts5-HA tagged strains incubated for overnight at 4°C. The beads were then washed with TRIS lysis buffer (50 mM TrisCl, PH 7.7; 150 mM NaCl; 5mM EDTA; 5% Glycerol; 1% Triton X; 1 mM PMSF; complete EDTA-free protease inhibitor cocktail tablets (Roche Applied Science)) and separated by SDS polyacrylamide gel and analyzed by western blot using mouse monoclonal Anti-HA antibodies (Covance; RRID:[AB_2314672](https://scicrunch.org/resolver/AB_2314672)). To inhibit Orb6 kinase, cells were incubated with either DMSO or 50 μM 1-NA-PP1 for 15 min at 32°C.

RNA fluorescence in situ hybridization (FISH) {#s4-15}
---------------------------------------------

The subcellular localization of *ssp1* mRNA in cells expressing Sts5-3xGFP and Dcp1-mCherry was visualized using FISH, and our method was adapted from previously described protocols ([@bib34]; [@bib74]; [@bib9]) with the following modifications. Custom Stellaris DNA probes targeted against *ssp1* mRNA were coupled to Quasar 705 (BioSearch Technologies). Cells were fixed with 4% paraformaldehyde for 20 min at room temperature and washed with buffer B (1.2 M sorbitol, 100 mM KHPO~4~, pH 7.5) Cell walls were digested for 30 min in spheroplast buffer (1.2 M sorbitol, 100 mM KHPO~4~ at pH 7.5, 20mM vanadyl ribonucleoside complex, 20 μM β-mercaptoethanol) containing 5% Zymolyase 20T at room temperature. Cells were pelleted (taking care to spin cells at ≤500 rpm for 3--5 min between washes in steps after the Zymolyase digestion) then washed in buffer B. Cells were then incubated in 1 mL of -80°C methanol, stored overnight at -20°C, incubated in 1 mL of acetone for 1 min, and then washed twice in 1 mL of 2X SSC (0.3 M NaCl, 30 mM sodium citrate). Cells were preincubated at 37°C in 50 μl of hybridization buffer, consisting of a 1:1 ratio of Buffer F (20% formamide, 10 mM NaHPO4 at pH 7.0) and Buffer H (4X SSC, 4 mg/ml,1 purified BSA and 20mM vanadyl ribonuclease complex) and 2 μl of 10-mg/ml salmon-sperm DNA (which was boiled for 3 min at 95°C). After 1 hr of prehybridization, 0.5 μl of 12.5 μM Quasar 705-conjugated *ssp1* probe was added, and the cells were incubated at 37°C for 5 hr. Cells were washed two times with 2X SSC and resuspended in 2X SSC buffer. Object-based colocalization analysis (based on the distance between centers of mass) was performed using the ImageJ plugin JACoP (Just Another Colocalization Plugin) ([@bib5]). For threshold selection, we adapted a method similar to one previously described for image threshold selection of RNA FISH images ([@bib79]). Specifically, we applied a Laplacian of Gaussian filter to reduce noise and highlight areas of rapid change in each cell and chose the threshold where the histogram reached a plateau, indicating a region where above-background pixels can be clearly detected.

Glucose depletion in Orb6 overexpressing cells {#s4-16}
----------------------------------------------

pREP3X-Orb6- and pREP3X-carrying cells expressing Sts5-3xGFP and Dcp1p-mCherry were grown in absence of thiamine for 18 hr at 32°C. Cells were then washed once in minimal medium minus glucose and resuspended in minimal medium containing 2% or 0% glucose and the required supplements. Cultures were incubated at 32°C for 1 hr before visualizing the localization of Sts5-3xGFP and Dcp1-mCherry using fluorescence microscopy.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

\[Editors' note: this article was originally rejected after discussions between the reviewers, but the authors were invited to resubmit after an appeal against the decision.\]

Thank you for submitting your work entitled \"Spatial control of translation repression and polarized growth by conserved NDR kinase Orb6 and RNA-binding protein Sts5\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, including Aaron Gitler, and the evaluation has been overseen by J. Paul Taylor as Reviewing Editor and James Manley as the Senior Editor. Our decision has been reached after consultation between the reviewers. Based on these discussions and the individual reviews below, we regret to inform you that the current submission of your work cannot be considered further for publication in *eLife*, at least in its current form.

Please be aware that the Senior Editor, the Reviewing Editor and the 3 additional referees deliberated extensively over this submission. The mechanism described -- phosphorylation-dependent control of RNA-binding protein assembly with P-bodies, with consequential spatial and temporal regulation of the expression of a subset of mRNAs -- is of great interest to us. The major weakness is insufficient characterization of mRNA interactions with Sts5, demonstration of spatial redistribution of these mRNAs to P-bodies, and correlation with changes in mRNA stability. These concerns, in addition to those elaborated by the reviewers below, would require more extensive additional work than we typically allow for in a revision. We request that revised manuscripts be returned within 2 months. That said, if you are able to address these concerns fully, we would encourage submitting a new manuscript to *eLife*.

Reviewer \#1:

Non membrane-delimited subcellular compartments play critical cellular functions essential for life. These include P-bodies and stress granules (SGs), which are composed of RNAs and RNA-binding proteins. Many of the protein constituents of SGs and P-bodies contain domains resembling yeast prions (called prion-like domains or low-complexity domains). These domains afford the protein a remarkable ability to undergo phase transitions. There has been an emergence of interest in this phenomenon since it has broad implications on gene regulation and many other facets of biology.

This new manuscript by Verde and colleagues presents a very exciting discovery showing how a similar phenomenon can be used to regulate polarized cell growth. They show that the fission yeast protein Sts5 forms RNA granule like accumulations during mitosis and this is negatively regulated by a kinase, Orb6. Remarkably, the aggregation of Sts5 serves to sequester certain key polarized growth protein encoding mRNAs. This is a novel example of how regulated aggregation can be harnessed by cell biology to regulate a fundamental biological process.

The authors have combined high quality imaging, biochemistry, and mRNA analyses to provide compelling evidence to support this novel cellular function for Orb6 and Sts5. In a broader way, they have opened up the possibility that similar phase separations can be harnessed in biology to regulate many other fundamental processes.

In my opinion, this manuscript will be of interest to the readers of *eLife* and will make an important conceptual advance. There is only one area that I suggest the authors consider:

Several recent studies have demonstrated that some RNA-binding proteins, such as hnRNPA1 and FUS can undergo liquid-liquid demixing *in vitro* (e.g., Patel et al., Cell 2015; Molliex et al., Cell 2015; Lin et al., Mol Cell 2015). I suggest the authors perform experiments *in vitro* to see if Sts5 can form similar liquid compartments and, if so, if the phosphorylation by Orb6 alters these properties. One part of this story that seems less well developed is the precise role of Orb6 in negatively regulating Sts5 aggregation. The *in vitro* experiments with defined components might help to better define this mechanism.

Reviewer \#2:

This manuscript presents a novel (to my knowledge) study into links between polarized growth and mRNA regulation in *S. pombe*. The authors provide both genetic and biochemical evidence for negative regulation of the RNA-binding protein, Sts5, by the NDR kinase, Orb6. Orb6 inhibits Sts5 assembly into puncta, the association with P-bodies, and degradation of Sts5 target mRNAs. They show that Orb6 acts through regulating Sts5\'s interaction with Rad24.

This work describes a new role for Orb6 kinase in the control of polarized growth independent of Cdc42 pathways. The broad interest and novelty of the work are related to the molecular regulation of RNP body assembly and function by a conserved kinase and the ability to see this regulation highly spatially controlled in the cytoplasm. Below are suggested experiments that could solidify the links in the model but overall I am in favor of publishing this manuscript.

1\) The evidence of translational control is limited to a single protein ([Figure 3](#fig3){ref-type="fig"}). The authors present evidence that Orb6 inhibits Sts5-association with P-bodies. This in turn promotes stability and perhaps translation of Sts5 bound mRNAs encoding polarity factors. Confidence in the generality of this mechanism would be increased levels of other putative proteins were measured and if Ssp1 was more deeply analyzed. Are Ssp1 protein levels changing in a different mutant that cannot form P-bodies? Do Ssp1 levels change during cell stress and cell division when Sts5 is clearly forming cytoplasmic puncta?

2\) Are the mRNAs identified by microarray as controlled by Sts5 changing localization consistent with the model of spatial control of repression/degradation/translation? It would be good to have some other validation of mRNA regulation beyond just the microarrays. Would it be possible to try single molecular RNA FISH and see how distribution changes from clustered as would be if in large RNPs or distributed throughout cytosol? This tool would allow the visualization of local changes in localization of Sts5 mRNA targets in response to Orb6 inhibition or cellular stress and help distinguish, potentially, between the functions of the mitotic Sts5 puncta and P-bodies.

3\) Is Sts5 an in vivo target of Orb6 in cells? The results suggest that Orb6-dependent phosphorylation of Sts5 regulates its association with P-bodies or Rad24. Although the authors present an *in vitro* kinase assay result to demonstrate that Orb6 can phosphorylate Sts5, further evidence of Sts5 as a direct substrate in vivo would be more convincing. This in turn would allow the generation of mutants that are not phosphorylatable to actually demonstrate that phosphorylation is the trigger of disassembly of cytoplasmic puncta. Alternatively, does Sst5 form \"aggregates\" *in vitro* and are these disassembled by Orb6 kinase?

4\) Does Orb6 overexpression cause an inability of the cell to react properly to stress?

Reviewer \#3:

In this manuscript, the authors show that the lethality of the NDR kinase Orb6 can be suppressed by loss of function in the RNA-binding protein Sts5. They show that Sts5 is phosphorylated by Orb6 kinase, which promotes its association with 14-3-3; forms aggregates upon starvation or upon loss of Orb6 activity; and associates with several mRNAs, including *ssp1* mRNA. Sts5 loss of function leads to increased levels of these and other mRNAs, indicating Ssp5 promotes mRNA degradation. They propose that Orb6 phosphorylation of Sts5 promotes its association of 14-3-3 to antagonize its association with P-bodies, thus preventing the degradation of key mRNA for polarized growth. They further propose that this regulation is spatially regulated, with Sts5 aggregates forming preferentially at the non-growing cell end of monopolar cells; and temporally regulated, with Orb6-mediated inhibition taking place during mitosis and cytokinesis but being relieved upon contractile ring closure.

The ideas put forward by this study are interesting and largely novel. However, I find that several parts of the model are not well supported by the data shown, with some inconsistencies. Several key points are overstated in the text relative to the data shown, which in aggregate fail to convince me of the whole narrative. These are detailed below.

Genetic interaction of *sts5* and *orb6* ([Figure 1](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}):

The authors identify *sts5* loss-of-function as suppressor of *orb6* mutation lethality and show some evidence that this suppression is separable from the role of Orb6 in regulating Cdc42 activity. The suppression data is convincing, but the separation of function is less so. In the growth assay shown in [Figure 1---figure supplement 2A](#fig1s2){ref-type="fig"}, single colonies cannot be seen in the higher dilutions and the *gef1∆* single mutant strain appears very sick. From this assay, one could argue that the *gef1∆ orb6-as* double mutant actually grows better than the single mutant. This should be clarified. In addition, if the *orb6-sts5* control of growth is really genetically separable from the spatial control of Cdc42, this would predict that Sts5 loss of function does not correct the round shape of *orb6* mutants (at permissive temperature) because of Cdc42 activity presence on cell sides, i.e. *sts5-276 orb6-as* double mutant treated with PP1 inhibitor at 25°C should be round. Is this the case?

I am not sure I understand exactly what is quantified in [Figure 1---figure supplement 1C](#fig1s1){ref-type="fig"}. In [Figure 1B](#fig1){ref-type="fig"}, it is shown that 60% of *orb6-as2* cells are septated. In [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}, only non-septated cells are shown with CRIB signal on cell sides, with quantification that amounts to 80%. Clearly 60+80\>100, so I am not sure how to reconcile these numbers. If only a subset of cells is quantified, this should be specified. Also, in [Figure 1B](#fig1){ref-type="fig"}, the authors indicate a standard deviation from only n=2 experiments, which cannot be derived.

Formation of Sts5 punctae, association with P-bodies, mRNA degradation and regulation by Orb6:

The authors show that starvation or Orb6 kinase inhibition leads to formation of Sts5 punctae that colocalize with P-body marker Dcp1. Sts5 loss of function also leads to a reduction in the number of P-bodies after Orb6 inhibition, implicating Sts5 in the formation of P-bodies. However, they do not examine the role of Sts5 in P-body formation upon starvation, when P-body structures are much more prominent. Does Sts5 also play a role in the formation of P-bodies upon starvation? During N-starvation, it looks like there is only a partial colocalization of Sts5 with Dcp1. This should be stated in the text.

Regarding mRNA levels, the data on *ssp1* mRNA level regulation is convincing, with epistasis of Sts5 over Orb6, indicating that Orb6 prevents Sts5-mediated degradation of Ssp1 mRNA. However, epistasis is not shown for any of the other transcripts examined. This would be required for the authors to make their claim of a general finding.

The link between aggregate formation, P-bodies and mRNA degradation is also not clear. The authors state, in the Results section, subsection "Orb6 kinase inhibits Sts5 aggregation and Sts5 localization to P-bodies", that \"Orb6 kinase prevents \[\...\] Sts5 localization to P-bodies, with the effect of preventing the degradation of specific mRNAs\" and, in the sixth paragraph of the Discussion section, that \"Sts5 promotes mRNA degradation likely by recruiting transcripts to processing (P) bodies\". However, the observed increased level of several mRNAs in the *sts5∆* strain does not correlate with the colocalization of Sts5 with P-bodies: the latter is shown upon starvation, whereas the mRNA levels are examined in normal growth conditions. Similarly, in *rad24∆* where there is no obvious colocalization of Sts5 with P-body markers, the authors claim Ssp1 levels are reduced (whether this is actually the case is also an issue -- see below). From this, it appears that formation of aggregates and mRNA level regulation are not causally linked. It is equally possible that aggregation is a consequence of the *sts5* interaction with/degradation of mRNAs or that the two effects or not directly causally related.

The kinase assay in [Figure 6A](#fig6){ref-type="fig"} lacks a negative control to state that Orb6 kinase phosphorylates Sts5. What is shown is that a Mob2-associated kinase phosphorylates Sts5. This may indeed be Orb6, but should be accurately described in the text.

Kinase assay and 14-3-3 role:

This part is not very convincing with text and figures showing a number of inconsistencies and over-interpretations.

The authors state (Results section, subsection "14-3-3 protein Rad24 negatively regulates Sts5 aggregation") that \"*ssp1* mRNA levels are consistently reduced in *rad24∆* mutants\", but the data shown in [Figure 6E](#fig6){ref-type="fig"} does not state a statistically significant difference between wt and *rad24∆* strains. The fact that the levels are significantly reduced in *rad24∆* compared to *sts5∆* or *sts5∆ rad24∆* double mutants does not indicate anything about the possible role of Rad24, simply that Sts5 promotes Ssp1 degradation.

Similarly, the authors propose on later in the Results section that \"Orb6 inhibits \[\...\] Sts5 localization to P-bodies by promoting its interaction with 14-3-3 protein Rad24.\" However, the data shows that Sts5 forms aggregates in *rad24∆* cells, but I do not see evidence that they contain Dcp1 P-body marker (see [Figure 6C](#fig6){ref-type="fig"}). The authors indeed actually write that P-body formation is not strongly induced in *rad24∆*.

Temporal regulation:

The proposed anti-correlation of Ssp5 aggregates with Orb6 activity during cell division is interesting, but is poorly supported. Previous work had shown that Orb6 activity is inhibited by SIN signaling until closure of the contractile ring. Here, the authors rely solely on this published evidence to propose a causal link between Ssp5 aggregate dissipation during septation and Orb6 activity. They should at least precisely quantify the number of aggregates over time during cytokinesis. For this a timelapse acquisition of Sts5-3xGFP would be best, relative to a cytokinesis marker to time the progression of ring constriction. They should also show that any disappearance of Sts5 aggregates is indeed due to Orb6 activity, using either of their *orb6-as* or *orb6* ts alleles.

The localization of Orb6-GFP during cell division, claimed to be shown in Figure 7---figure supplement 2C, is not shown. That figure legend is also present at the bottom of [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}.

The cell lysis phenotype of *sts5∆* cells should be quantified.

Spatial regulation:

In general, the spatial regulation of this mRNA stabilization control is not very convincing. The asymmetry in the aggregates of Sts5 is rather difficult to see. It is well documented in *tea1∆* cells, but less so in wt cells. Could the authors provide more examples to show the Sts5 asymmetric localization in monopolar wt cells? The authors propose the existence of an Sts5 phosphorylation gradient. This is an interesting idea, with conceptual similarity to gradients of MEX-5 in *C. elegans* that contribute to the dissolution of P-granules, but is it actually possible at the small scale of a yeast cell? Diffusion rates in the cytosol, if Sts5 diffuses unimpeded, makes this unlikely, but it could be constrained through aggregate formation. Examination of the motility of Sts5 aggregates would help to resolve this point.

I am also not convinced that Sts5 has a direct role in regulating bipolar growth. As the *sts5∆* mutant cells are longer at all densities examined, the increased proportion of bipolar cells could simply be a result of the longer cell length. It is well established that fission yeast cells have a cell size-dependent regulation of bipolarity. The authors instead seem to argue that the increased length is a consequence of increased bipolarity, but I do not see evidence for this. For cells of equal initial length, are the *sts5∆* mutant cells growing faster? Are cells of same length more bipolar if *sts5∆*?

Allele nomenclature and temperature sensitivity:

The nomenclature of the alleles used is confusing. It should be clearly stated in the text that *orb4* and *sts5* are two names for the same gene (and as much as possible use a single gene name throughout the manuscript), and that the alleles used are both early stop codons. The authors also use a deletion of the gene, but it is not very clear which strain is used in which experiment, and why different strains were used. For instance, in second paragraph of Results section, the authors say they \"examined whether *sts5* deletion also suppresses the loss of polarity observed upon Orb6 kinase inhibition\", but the figure referred to ([Figure 1---figure supplement 1B-C](#fig1s1){ref-type="fig"}) states use of *orb4-A9* allele.

More generally, I do not understand the use of different \"permissive\", \"semi-permissive\" and \"restrictive\" temperatures to examine the phenotype of *sts5* loss of function. In what way are the alleles used conditional if these are either early stop codons or deletions? This should be clearly stated and discussed. For instance, the increased levels of Ssp1-HA in *sts5* mutants is only shown to happen at 36°C, but the text states that the increased levels are \"exaggerated\" at 36°C (Results section, subsection "Loss of Sts5 leads to increased levels of mRNAs involved in growth control and bipolar growth activation"), which implies it is also the case at lower temperature.

\[Editors' note: what now follows is the decision letter after the authors submitted for further consideration.\]

Thank you for submitting your article \"Spatial control of translation repression and polarized growth by conserved NDR kinase Orb6 and RNA-binding protein Sts5\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, including Aaron D Gitler (Reviewer \#1), and the evaluation has been overseen by a Reviewing Editor and James Manley as the Senior Editor.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission. We hope you will be able to submit the revised version within two months, so please let us know if you have any questions first.

Summary:

This manuscript presents novel insight into a link between mRNA regulation and polarized growth in *S. pombe*. The authors present genetic and biochemical evidence indicating that NDR kinase Orb6 negatively regulates the RNA-binding protein Sts5. Orb6 activity alters an interaction of Sts5 with 14-3-3, regulating the ability of Sts5 to assemble into cytoplasmic P-bodies, which sequester and influence the stability of Sts5 target mRNAs. There was consensus among the reviewers that the additional data and analyses provided in the revised manuscript addressed most of the concerns from the original review, but several issues remain that must be addressed.

Essential revisions:

1\. The FISH experiment showing colocalization of *ssp1* mRNA with Sts5 (and Dcp1) granules is a nice addition. However, in addition to showing representative images the extent of colocalization should quantified.

2\. Similarly, the analysis of Efc25 protein levels is a nice addition, though it needs to be quantified. An epistasis experiment to test whether deletion of *sts5* abrogates the reduction in Efc25 levels observed in *orb6* mutant (as shown for Ssp1) would further support the conclusion.

3\. In [Figure 6E](#fig6){ref-type="fig"}, the statistical comparisons should be done between *rad24∆* and wt, not between *rad24∆* and *sts5∆*.

10.7554/eLife.14216.030

Author response

\[Editors' note: the author responses to the first round of peer review follow.\]

Thank you for submitting your work entitled \"Spatial control of translation repression and polarized growth by conserved NDR kinase Orb6 and RNA-binding protein Sts5\" for consideration by eLife. Your article has been reviewed by three peer reviewers, including Aaron Gitler, and the evaluation has been overseen by J. Paul Taylor as Reviewing Editor and James Manley as the Senior Editor. Our decision has been reached after consultation between the reviewers. Based on these discussions and the individual reviews below, we regret to inform you that the current submission of your work cannot be considered further for publication in eLife, at least in its current form.

*Please be aware that the Senior Editor, the Reviewing Editor and the 3 additional referees deliberated extensively over this submission. The mechanism described -- phosphorylation-dependent control of RNA-binding protein assembly with P-bodies, with consequential spatial and temporal regulation of the expression of a subset of mRNAs -- is of great interest to us. The major weakness is insufficient characterization of mRNA interactions with Sts5, demonstration of spatial redistribution of these mRNAs to P-bodies, and correlation with changes in mRNA stability. These concerns, in addition to those elaborated by the reviewers below, would require more extensive additional work than we typically allow for in a revision. We request that revised manuscripts be returned within 2 months. That said, if you are able to address these concerns fully, we would encourage submitting a new manuscript to eLife.*

Reviewer \#1:

*\[...\] In my opinion, this manuscript will be of interest to the readers of eLife and will make an important conceptual advance. There is only one area that I suggest the authors consider:*

*Several recent studies have demonstrated that some RNA-binding proteins, such as hnRNPA1 and FUS can undergo liquid-liquid demixing* in vitro *(e.g., Patel et al., Cell 2015; Molliex et al., Cell 2015; Lin et al., Mol Cell 2015). I suggest the authors perform experiments* in vitro *to see if Sts5 can form similar liquid compartments and, if so, if the phosphorylation by Orb6 alters these properties. One part of this story that seems less well developed is the precise role of Orb6 in negatively regulating Sts5 aggregation. The* in vitro *experiments with defined components might help to better define this mechanism.*

Sts5 protein contains a predicted unstructured N terminal domain in the first 301 amino acids. We have included this finding in the current version of the paper ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). The role of unstructured domains in the formation of liquid compartments and cytoplasmic phase transition is a biological problem of fundamental importance, and we plan to devote substantial effort in the future to reconstitute the behavior of Sts5 in vitro. At the moment however, we feel these experiments are beyond the scope of this paper, and it would require an entire additional manuscript to present them completely and well controlled. Also, the phosphorylation studies are complicated by the existence of other phosphorylated sites in the Sts5 molecule by which other kinases may contribute to its regulation (results of proteomic analysis: Wilson-Grady et al., 2008; Koch et al., 2011; Carpy et al., 2014; Kettenbach et al., 2015), and that may, at this time, confound the in vitro experiments.

*Reviewer \#2:*

*\[...\] This work describes a new role for Orb6 kinase in the control of polarized growth independent of Cdc42 pathways. The broad interest and novelty of the work are related to the molecular regulation of RNP body assembly and function by a conserved kinase and the ability to see this regulation highly spatially controlled in the cytoplasm. Below are suggested experiments that could solidify the links in the model but overall I am in favor of publishing this manuscript.*

*1) The evidence of translational control is limited to a single protein ([Figure 3](#fig3){ref-type="fig"}). The authors present evidence that Orb6 inhibits Sts5-association with P-bodies. This in turn promotes stability and perhaps translation of Sts5 bound mRNAs encoding polarity factors. Confidence in the generality of this mechanism would be increased levels of other putative proteins were measured and if Ssp1 was more deeply analyzed. Are Ssp1 protein levels changing in a different mutant that cannot form P-bodies? Do Ssp1 levels change during cell stress and cell division when Sts5 is clearly forming cytoplasmic puncta?*

We further characterized Efc25, the protein encoded by Sts5-bound *efc25* mRNA, whose levels increase in *sts5Δ* cells and decrease in *orb6* mutant cells. We found that Efc25 protein levels increase in *sts5Δ* cells and decrease in *orb6* mutants, similarly to Ssp1 protein (see Figure 3---figure supplement 1; Figure 5---figure supplement 1E).

As far as Ssp1 protein levels in mutants that cannot form P-bodies areconcerned, we have tested Ssp1 levels in *pdc1Δ* and *edc3Δ* mutant cells that encode Pbody components that regulate mRNA decapping. We found that Ssp1 protein levels are increased in the *pdc1Δ* and *edc3Δ* backgrounds (see [Figure 3 E and F](#fig3){ref-type="fig"}).

*2) Are the mRNAs identified by microarray as controlled by Sts5 changing localization consistent with the model of spatial control of repression/degradation/translation? It would be good to have some other validation of mRNA regulation beyond just the microarrays. Would it be possible to try single molecular RNA FISH and see how distribution changes from clustered as would be if in large RNPs or distributed throughout cytosol? This tool would allow the visualization of local changes in localization of Sts5 mRNA targets in response to Orb6 inhibition or cellular stress and help distinguish, potentially, between the functions of the mitotic Sts5 puncta and P-bodies.*

Consistent with Sts5 controlling the localization of *ssp1* mRNA, we found that *ssp1* fluorescent RNA FISH probes (Stellaris) colocalize with a subset of Sts5-GFP and Dcp1- mCherry containing punta in glucose-starved cells (see [Figure 3G](#fig3){ref-type="fig"} and Figure 3---figure supplement 1 D). Our results are consistent with experiments published by other investigators, for example by the laboratory of Roy Parker, whose protocol we adapted (Brengues and Parker, 2007).

*3) Is Sts5 an* in vivo *target of Orb6 in cells? The results suggest that Orb6-dependent phosphorylation of Sts5 regulates its association with P-bodies or Rad24. Although the authors present an* in vitro *kinase assay result to demonstrate that Orb6 can phosphorylate Sts5, further evidence of Sts5 as a direct substrate* in vivo *would be more convincing. This in turn would allow the generation of mutants that are not phosphorylatable to actually demonstrate that phosphorylation is the trigger of disassembly of cytoplasmic puncta. Alternatively, does Sst5 form \"aggregates\"* in vitro *and are these disassembled by Orb6 kinase?*

Sts5 protein contains an unstructured N-terminal domain comprising the first 301 amino acids ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). However it is not recruited into RNPs in the absence of the mRNA-binding domain. The Sts5 sequence presents several canonical Orb6 consensus sites and other lower affinity Orb6 consensus sites that may also need to be modified to ensure maximal response. Also, the phosphorylation studies are complicated by the existence of other phosphorylated sites by other kinases in different domains of the Sts5 molecule that may contribute to its regulation (results of proteomic analysis (Wilson-Grady et al., 2007; Koch et al., 2011; Carpy et al., 2014; Kettenbach et al., 2015), and that may confound in vitro experiments. These are interesting experiments however, and are going to be the subject of extensive efforts in the lab in the future.

*4) Does Orb6 overexpression cause an inability of the cell to react properly to stress?*

Nutritional stress induces Sts5 recruitment to RNPs and P-body formation. Thus, we used Sts5 recruitment to RNPs and P-body formation as a read-out of stress. We have over-expressed Orb6 kinase and monitored P-body formation and Sts5 recruitment to RNPs upon glucose deprivation. We found that Orb6 overexpression significantly decreases the intensity of Sts5 puncta and P-bodies (see Figure 5--- figure supplement 2A).

*Reviewer \#3:*

*In this manuscript, the authors show that the lethality of the NDR kinase Orb6 can be suppressed by loss of function in the RNA-binding protein Sts5. They show that Sts5 is phosphorylated by Orb6 kinase, which promotes its association with 14-3-3; forms aggregates upon starvation or upon loss of Orb6 activity; and associates with several mRNAs, including ssp1 mRNA. Sts5 loss of function leads to increased levels of these and other mRNAs, indicating Ssp5 promotes mRNA degradation. They propose that Orb6 phosphorylation of Sts5 promotes its association of 14-3-3 to antagonize its association with P-bodies, thus preventing the degradation of key mRNA for polarized growth. They further propose that this regulation is spatially regulated, with Sts5 aggregates forming preferentially at the non-growing cell end of monopolar cells; and temporally regulated, with Orb6-mediated inhibition taking place during mitosis and cytokinesis but being relieved upon contractile ring closure.*

*The ideas put forward by this study are interesting and largely novel. However, I find that several parts of the model are not well supported by the data shown, with some inconsistencies. Several key points are overstated in the text relative to the data shown, which in aggregate fail to convince me of the whole narrative. These are detailed below.*

*Genetic interaction of sts5 and orb6 ([Figure 1](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}):*

*The authors identify sts5 loss-of-function as suppressor of orb6 mutation lethality and show some evidence that this suppression is separable from the role of Orb6 in regulating Cdc42 activity. The suppression data is convincing, but the separation of function is less so. In the growth assay shown in [Figure 1---figure supplement 2A](#fig1s2){ref-type="fig"}, single colonies cannot be seen in the higher dilutions and the gef1∆ single mutant strain appears very sick. From this assay, one could argue that the gef1∆ orb6-as double mutant actually grows better than the single mutant. This should be clarified.*

The growth delay of the *gef1Δ* strain observed in [Figure 1---figure supplement 2A](#fig1s2){ref-type="fig"}, as compared to *gef1Δ orb6-as2*, in the control DMSO condition, was due to a difference in the background of the strains. The *gef1Δ* strain was burdened by *ura4Δ* and *leu1-32* auxotrophic markers, which produced a growth difference even in the presence of exogenously added supplements. We have repeated these experiments with a different *gef1Δ* strain that does not contain these mutations, and found no difference in growth between *gef1Δ* and *gef1Δ orb6-as2* in DMSO. (See [Figure 1---figure supplement 2A](#fig1s2){ref-type="fig"})

*In addition, if the orb6-sts5 control of growth is really genetically separable from the spatial control of Cdc42, this would predict that Sts5 loss of function does not correct the round shape of orb6 mutants (at permissive temperature) because of Cdc42 activity presence on cell sides, i.e. sts5-276 orb6-as double mutant treated with PP1 inhibitor at 25*°*C should be round. Is this the case?*

Indeed, we have analyzed *sts5Δ orb6-as2* double mutant cells, treated with 1- Na-PP1 inhibitor at 25°C for 5 hours, and found them to be round. We show this experiment in the current version of the paper (see [Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"})

*I am not sure I understand exactly what is quantified in [Figure 1---figure supplement 1C](#fig1s1){ref-type="fig"}. In [Figure 1B](#fig1){ref-type="fig"}, it is shown that 60% of orb6-as2 cells are septated. In [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}, only non-septated cells are shown with CRIB signal on cell sides, with quantification that amounts to 80%. Clearly 60+80\>100, so I am not sure how to reconcile these numbers. If only a subset of cells is quantified, this should be specified.*

In [Figure 1---figure supplement 1C](#fig1s1){ref-type="fig"} we quantified the extent of CRIB-GFP mis-localization only in non-septating cells (cells that do not contain a septum, which indeed is a subset). We have clarified this in the corresponding legend of the [Figure 1---figure supplement 1C and D](#fig1s1){ref-type="fig"}. Also, ectopic localization of CRIB-GFP is a rapid response that can be observed as early as 15 minutes after Orb6-as2 inhibition with 1-NA-PP1 (Das et al., 2009). Thus, the experimental conditions in the experiment depicted in [Figure 1---figure supplement 1C](#fig1s1){ref-type="fig"} and 1D are different than in [Figure 1B](#fig1){ref-type="fig"}, in which we quantified septation index after prolonged Orb6- as2 inhibition (2 hours) and the proportion of septated cells was different in the two experiments.

*Also, in [Figure 1B](#fig1){ref-type="fig"}, the authors indicate a standard deviation from only n=2 experiments, which cannot be derived.*

As also mentioned below, we counted almost 400 cells for each condition, giving us confidence in our conclusion. The reviewer, however, is correct to point out the issue with the standard deviation. In the revised version, we show in [Figure 1A](#fig1){ref-type="fig"} an entirely different set of three experiments using the *sts5Δ* strain, instead of the *orb4-A9* allele. This was done in response to point 6 of this reviewer, to simplify the use of different alleles. The results are entirely consistent with the previous experiment, and the 6 experiments were performed three times (see [Figure 1A](#fig1){ref-type="fig"}).

*Formation of Sts5 punctae, association with P-bodies, mRNA degradation and regulation by Orb6:*

*The authors show that starvation or Orb6 kinase inhibition leads to formation of Sts5 punctae that colocalize with P-body marker Dcp1. Sts5 loss of function also leads to a reduction in the number of P-bodies after Orb6 inhibition, implicating Sts5 in the formation of P-bodies. However, they do not examine the role of Sts5 in P-body formation upon starvation, when P-body structures are much more prominent. Does Sts5 also play a role in the formation of P-bodies upon starvation?*

As mentioned above, to address the role of Sts5 during nutritional stress we have performed additional experiments that were not included in the original version of the paper. In the current version, we show that loss of *sts5 (sts5Δ*) significantly decreases the intensity of P-bodies formed following glucose depletion. We added these experiments to the supplement section of the paper (Figure 5---figure supplement 2 B-D).

*During N-starvation, it looks like there is only a partial colocalization of Sts5 with Dcp1. This should be stated in the text.*

We have mentioned this fact in the text (Results section, subsection "Sts5 proteins are recruited into cytoplasmic puncta during mitosis and during nutritional starvation").

*Regarding mRNA levels, the data on ssp1 mRNA level regulation is convincing, with epistasis of Sts5 over Orb6, indicating that Orb6 prevents Sts5-mediated degradation of Ssp1 mRNA. However, epistasis is not shown for any of the other transcripts examined. This would be required for the authors to make their claim of a general finding.*

As mentioned above, we now characterize also *efc25*, another mRNA that copurifies with Sts5 protein, whose levels increase in *sts5Δ* cells and decrease in *orb6* mutant cells. Similarly to Ssp1 protein, Efc25 protein levels increase in *sts5Δ* cells and decrease in *orb6* mutants (see Figure 3---figure supplement 1; Figure 5---figure supplement 1, E).

*The link between aggregate formation, P-bodies and mRNA degradation is also not clear. The authors state, in the Results section, subsection "Orb6 kinase inhibits Sts5 aggregation and Sts5 localization to P-bodies", that \"Orb6 kinase prevents \[\...\] Sts5 localization to P-bodies, with the effect of preventing the degradation of specific mRNAs\" and, in the sixth paragraph of the Discussion section, that \"Sts5 promotes mRNA degradation likely by recruiting transcripts to processing (P) bodies\". However, the observed increased level of several mRNAs in the sts5∆ strain does not correlate with the colocalization of Sts5 with P-bodies: the latter is shown upon starvation, whereas the mRNA levels are examined in normal growth conditions. Similarly, in rad24∆ where there is no obvious colocalization of Sts5 with P-body markers, the authors claim Ssp1 levels are reduced (whether this is actually the case is also an issue -- see below). From this, it appears that formation of aggregates and mRNA level regulation are not causally linked. It is equally possible that aggregation is a consequence of the sts5 interaction with/degradation of mRNAs or that the two effects or not directly causally related.*

Indeed, our data indicates that in the absence of Sts5, levels of certain Sts5- associated mRNAs are increased even in the absence of extensive or visible P-body formation. Previous findings in *S. cerevisiae* indicate that mRNA degradation proceeds to a certain extent even in the absence of substantial P-body formation. Processes such as mRNA decay and RNA-mediated gene silencing (Eulalio et al., 2007) and mRNA 7 decapping and translational repression (Decker et al., 2007) are functional in cells lacking detectable microscopic P-bodies indicating that even though P-body components play crucial roles in mRNA silencing and decay, localization of mRNAs into large P-bodies is not necessary for function. Consistent with this idea, we find that loss of P-body components Pdc1 and Edc3 leads to a significant increase in Ssp1 protein levels, even in the absence of stress, when P-bodies are not visible (see [Figure 3E and F](#fig3){ref-type="fig"}).

As the reviewer mentions, our data also show that Sts5 recruitment into large RNPs in the *rad24Δ* strain does not trigger a substantial decrease in *ssp1* mRNA levels. Ssp1 mRNA levels, however, are decreased upon Orb6 kinase inhibition, which induces both P-body formation and Sts5 protein recruitment, in addition to other effects, such as Cdc42 activation. Thus, our data suggest that additional yet unknown signals, dependent on Orb6 kinase, are required for inducing mRNA degradation. We have clarified our conclusions in the current version of the paper (e.g. Results section, subsection "14-3-3 protein Rad24 negatively regulates Sts5 recruitment into cytoplasmic puncta"; fourth paragraph of Discussion section).

*The kinase assay in [Figure 6A](#fig6){ref-type="fig"} lacks a negative control to state that Orb6 kinase phosphorylates Sts5. What is shown is that a Mob2-associated kinase phosphorylates Sts5. This may indeed be Orb6, but should be accurately described in the text.*

We have changed the text to reflect this caveat (Results section, subsection "14-3-3 protein Rad24 negatively regulates Sts5 recruitment into cytoplasmic puncta").

*Kinase assay and 14-3-3 role:*

*This part is not very convincing with text and figures showing a number of inconsistencies and over-interpretations.*

*The authors state (Results section, subsection "14-3-3 protein Rad24 negatively regulates Sts5 aggregation") that \"ssp1 mRNA levels are consistently reduced in rad24∆ mutants\", but the data shown in [Figure 6E](#fig6){ref-type="fig"} does not state a statistically significant difference between wt and rad24∆ strains. The fact that the levels are significantly reduced in rad24∆ compared to sts5∆ or sts5∆ rad24∆ double mutants does not indicate anything about the possible role of Rad24, simply that Sts5 promotes Ssp1 degradation.*

*Similarly, the authors propose on later in the Results section that \"Orb6 inhibits.... Sts5 localization to P-bodies by promoting its interaction with 14-3-3 protein Rad24.\" However, the data shows that Sts5 forms aggregates in rad24∆ cells, but I do not see evidence that they contain Dcp1 P-body marker (see [Figure 6C](#fig6){ref-type="fig"}). The authors indeed actually write that P-body formation is not strongly induced in rad24∆.*

Our conclusion from experiments detailed in [Figure 6C](#fig6){ref-type="fig"} is that one of the roles of Orb6 kinase is to regulate association of Sts5 with Rad24 and prevent Sts5 recruitment into RNPs. Our experiments with *rad24Δ* mutant cells indeed show that Sts5 recruitment into RNPs occurs independently of substantial P-body formation, since these cells are not starved. We tried to be clearer in the current version of the paper. We speculate from our findings and propose that Sts5 protein regulation by Orb6 kinase is part of a mechanism ultimately regulating mRNA association with the P-bodies, since we see P-body formation upon Orb6 kinase inhibition. We also rephrased this part.

*Temporal regulation:*

*The proposed anti-correlation of Ssp5 aggregates with Orb6 activity during cell division is interesting, but is poorly supported. Previous work had shown that Orb6 activity is inhibited by SIN signaling until closure of the contractile ring. Here, the authors rely solely on this published evidence to propose a causal link between Ssp5 aggregate dissipation during septation and Orb6 activity. They should at least precisely quantify the number of aggregates over time during cytokinesis. For this a timelapse acquisition of Sts5-3xGFP would be best, relative to a cytokinesis marker to time the progression of ring constriction. They should also show that any disappearance of Sts5 aggregates is indeed due to Orb6 activity, using either of their orb6-as or orb6 ts alleles.*

We have quantified the number of Sts5 puncta during cytokinesis in the presence or absence of Orb6 kinase. As a marker for cytokinesis we used Rlc1, in addition to calcofluor. Rlc1, myosin II regulatory light chain (Le Goff et al., 2000) (Wu et al., 2006), disappears from the site of division when the actomyosin ring has fully contracted and the septum is closed (Wei, 2016). We found that Sts5 puncta are present as long as Rlc1 is present at the site of division (a sign that septum closure in not complete) but disappear in cells where Rlc1 has left the site of division, after septum closure. Indicating that disappearance of Sts5 puncta is indeed due to Orb6 activity, we find that Sts5 puncta are still visible in cells that have completed septum closure (and where Rlc1 has left the site of division), when Orb6 activity is inhibited. We show these experiments in the current version of the paper (see [Figure 7G and H](#fig7){ref-type="fig"}; Figure 7---figure supplement 2).

*The localization of Orb6-GFP during cell division, claimed to be shown in Figure 7---figure supplement 2, is not shown. That figure legend is also present at the bottom of Figure ---figure supplement 1.*

We indeed showed the localization of Orb6-GFP at the septum in [Figure 7---figure supplement 1A](#fig7s1){ref-type="fig"} (c), as the reviewer mentions. Figure 7---figure supplement 2C was a single typo, for which we apologize, as it should have read [Figure 7---figure supplement 1A](#fig7s1){ref-type="fig"} (c). We corrected this typo in the text.

*The cell lysis phenotype of sts5∆ cells should be quantified.*

We quantified the lysis phenotype of *sts5Δ* in triplicate experiments, and found that, under our experimental conditions, 43% of septating *sts5Δ* cells lyse at 36*°* C, as compared to 8% septating control cells. We added this information in the corresponding legend (see Figure 7---figure supplement 2).

*Spatial regulation:*

*In general, the spatial regulation of this mRNA stabilization control is not very convincing. The asymmetry in the aggregates of Sts5 is rather difficult to see. It is well documented in tea1∆ cells, but less so in wt cells. Could the authors provide more examples to show the Sts5 asymmetric localization in monopolar wt cells? The authors propose the existence of an Sts5 phosphorylation gradient. This is an interesting idea, with conceptual similarity to gradients of MEX-5 in C.elegans that contribute to the dissolution of P-granules, but is it actually possible at the small scale of a yeast cell? Diffusion rates in the cytosol, if Sts5 diffuses unimpeded, makes this unlikely, but it could be constrained through aggregate formation. Examination of the motility of Sts5 aggregates would help to resolve this point.*

Indeed, to verify the observation of asymmetric Sts5 puncta in small monopolar cells, first observed in wild-type cells, we used *tea1Δ* cells since they are 9 longer, stay monopolar, and localize Orb6-GFP at only one tip. We have added more examples of small wild-type cells that reflect the average representative localization under conditions of active cell growth (see [Figure 7---figure supplement 1A,D,E and F](#fig7s1){ref-type="fig"}). To avoid confusion or overstatements, we removed the word "gradient" that was originally proposed in the discussion.

*I am also not convinced that Sts5 has a direct role in regulating bipolar growth. As the sts5∆ mutant cells are longer at all densities examined, the increased proportion of bipolar cells could simply be a result of the longer cell length. It is well established that fission yeast cells have a cell size-dependent regulation of bipolarity. The authors instead seem to argue that the increased length is a consequence of increased bipolarity, but I do not see evidence for this. For cells of equal initial length, are the sts5∆ mutant cells growing faster? Are cells of same length more bipolar if sts5∆?*

In response to this reviewer's comments, we have performed two additional sets of experiments. We show that *sts5Δ* cells display increased bipolarity even during exponential cell growth, when *sts5Δ* cells display the same size (average cell length at division; see [Figure 8C](#fig8){ref-type="fig"}). As this reviewer suggested, we measured the percentage of bipolar cells in cells of similar length (less than 10 micrometers; from 10 to 12; more than 12), and found that *sts5Δ* cells display an increased percentage of bipolar cells as compared to controls (see [Figure 8---figure supplement 1, A](#fig8s1){ref-type="fig"}) even if *sts5Δ* cells display the same growth rate as control *sts5*+ cells ([Figure 8---figure supplement 1B](#fig8s1){ref-type="fig"}).

*Allele nomenclature and temperature sensitivity:*

*The nomenclature of the alleles used is confusing. It should be clearly stated in the text that orb4 and sts5 are two names for the same gene (and as much as possible use a single gene name throughout the manuscript), and that the alleles used are both early stop codons. The authors also use a deletion of the gene, but it is not very clear which strain is used in which experiment, and why different strains were used. For instance, in second paragraph of Results section, the authors say they \"examined whether sts5 deletion also suppresses the loss of polarity observed upon Orb6 kinase inhibition\", but the figure referred to ([Figure 1---figure supplement 1B-C](#fig1s1){ref-type="fig"}) states use of orb4-A9 allele.*

We have redone the experiments in [Figure 1A](#fig1){ref-type="fig"}, using the *sts5Δ* allele, and obtained identical results to the *orb4-A9* allele. Aside from growth suppression experiments detailed in [Figure 1E](#fig1){ref-type="fig"} (done some time ago with the *sts5-276* allele by our collaborators at Hiroshima University) and one control experiment with CRIB-GFP (which was part of the initial screening with *orb4-A9* allele; [Figure 1---figure supplement 1C,D](#fig1s1){ref-type="fig"}), all other experiments were performed using the *sts5Δ* allele. As the reviewer mentions, these are all early stop codons, and we never found the corresponding mutants to behave differently from the *sts5Δ* deletion mutant cells. We mentioned this aspect in the legend of [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}.

*More generally, I do not understand the use of different \"permissive\", \"semi-permissive\" and \"restrictive\" temperatures to examine the phenotype of sts5 loss of function. In what way are the alleles used conditional if these are either early stop codons or deletions? This should be clearly stated and discussed. For instance, the increased levels of Ssp1-HA in sts5 mutants is only shown to happen at 36°C, but the text states that the increased levels are \"exaggerated\" at 36°C (Results section, subsection "Loss of Sts5 leads to increased levels of mRNAs involved in growth control and bipolar growth activation"), which implies it is also the case at lower temperature.*

In the current version of the paper, for clarity, we decided not use "restrictive" or "permissive" definitions and just state the temperature at which experiments are performed. The use of "restrictive" or "permissive" temperature refers to conditional, temperature-sensitive phenotypes, and thus it is a functional definition. Indeed *sts5Δ* displays a morphological phenotype that is temperature-sensitive: it is cylindrical in shape (albeit with an increase in the extent of cell growth at the new end) at 25*°*C, while it is enlarged and round at 36*°*C. These phenotypes likely reflect a decreased ability for *sts5Δ* cells to adapt to higher temperatures. We changed the wording in seventh paragraph, Results section.

\[Editors' note: the author responses to the re-review follow.\]

*Thank you for submitting your article \"Spatial control of translation repression and polarized growth by conserved NDR kinase Orb6 and RNA-binding protein Sts5\" for consideration by eLife. Your article has been reviewed by three peer reviewers, including Aaron D Gitler (Reviewer \#1), and the evaluation has been overseen by a Reviewing Editor and James Manley as the Senior Editor.*

*The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission. We hope you will be able to submit the revised version within two months, so please let us know if you have any questions first.*

*Summary:*

*This manuscript presents novel insight into a link between mRNA regulation and polarized growth in S. pombe. The authors present genetic and biochemical evidence indicating that NDR kinase Orb6 negatively regulates the RNA-binding protein Sts5. Orb6 activity alters an interaction of Sts5 with 14-3-3, regulating the ability of Sts5 to assemble into cytoplasmic P-bodies, which sequester and influence the stability of Sts5 target mRNAs. There was consensus among the reviewers that the additional data and analyses provided in the revised manuscript addressed most of the concerns from the original review, but several issues remain that must be addressed.*

*Essential revisions:*

*1. The FISH experiment showing colocalization of ssp1 mRNA with Sts5 (and Dcp1) granules is a nice addition. However, in addition to showing representative images the extent of colocalization should quantified.*

We have quantified the co-localization of *ssp1* mRNA and Sts5 (and Dcp1) granules, and added these data in [Figure 4---figure supplement 3B and C](#fig4s3){ref-type="fig"}. We used the ImageJ plugin JACoP (Just Another Colocalization Plugin) to perform object-based quantification based on the distance between centers of mass of puncta (Bolte and Cordelieres, 2006). We measured, respectively, the proportion of *ssp1* puncta colocalizing with Sts5-3xGFP or Dcp1-mCh ([Figure 4---figure supplement 3B](#fig4s3){ref-type="fig"}), and the proportion of Sts5-3xGFP or Dcp1-mCh puncta colocalizing with *ssp1* puncta ([Figure 4---figure supplement 3C](#fig4s3){ref-type="fig"}), in three independent experiments, in the presence or absence of glucose.

*2. Similarly, the analysis of Efc25 protein levels is a nice addition, though it needs to be quantified. An epistasis experiment to test whether deletion of sts5 abrogates the reduction in Efc25 levels observed in orb6 mutant (as shown for Ssp1) would further support the conclusion.*

We have performed additional experiments, and showed that Efc25 levels decrease in inhibitor sensitive *orb6-as2* mutants ([Figure 6---figure supplement 1E](#fig6s1){ref-type="fig"}). We also found that *sts5* deletion abolishes the reduction of Efc25 levels in *orb6-as2* mutants ([Figure 6---figure supplement 1E](#fig6s1){ref-type="fig"}). We have quantified the results of three independent experiments in [Figure 6---figure supplement 1E](#fig6s1){ref-type="fig"}, right panel.

*3. In [Figure 6E](#fig6){ref-type="fig"}, the statistical comparisons should be done between rad24∆ and wt, not between rad24∆ and sts5∆.*

We have changed the [Figure 7E](#fig7){ref-type="fig"} ([Figure 8E](#fig8){ref-type="fig"} in the current manuscript)appropriately to reflect the message of the experiment, that there is not a significant difference in *ssp1* mRNA levels between *rad24∆* and *wt.* P values were determined using analysis of variance (ANOVA) with SPSS statistics package 22.0, followed by Games-Howell post-hoc test. We also removed the double mutant *sts5∆ rad24∆*, because as stated by the reviewers, it wasn't adding to the point of the figure.
